Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica

Sesión V: Bioequivalencia - Estudios de Permeabilidad: principios, metodologías y análisis de datos

Sesión en Español

Este webinar tiene como objetivo presentar los conceptos:

• Rutas de absorción oral de fármacos
• Transportadores intestinales
• Estudios de permeabilidad in vitro
• Impacto de excipientes sobre la absorción oral de fármacos
• Aplicaciones de los estudios de permeabilidad

Moderadora:
-Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil

Panelista:
-Pablo González, CEO Innovation and Biopharmaceutical Evaluation Center-Chile

Lebanon is grappling with an unprecedented economic and financial crisis which have been heightened by an ongoing pandemic and the devastation caused by the explosion in the heart of Beirut Port on 4th August 2020. In this episode, we talk to Dr Mohamad Hijazi from the faculty of pharmacy in Beirut Arab University in Lebanon to raise awareness about the unique experiences and challenges of pharmacists facing multiple crises in Lebanon.

Guest speaker: Dr Mohammad Ali Hijazi, Assistant Professor, Faculty of Pharmacy, Beirut Arab university, Beirut, Lebanon

About Dr Mohammad Ali Hijazi:
Dr. Mohamad Hijazi received his B.S. degree in Pharmacy from Beirut Arab University in 2007 with high distinction and honors. Based on his academic excellence, he was granted a master and Ph.D. degree scholarship from BAU in pharmaceutical sciences in 2010 & 2017 respectively.Dr. Hijazi joined the faculty of pharmacy at BAU as lecturer in 2014, and then promoted to Assistant Professor in 2017.

Counting on his diversified experience in pharmacy practice and education, he is responsible to develop and teach courses related to natural products therapy and pharmacy practice. In addition, he coordinates pharmacy students during their experiential learning at community pharmacies setting. He continuously struggles to raise the quality of teaching by implementing recent and diversified activities and assessment methodologies.

Dr. Hijazi has more than 15 years of experience in the various pharmaceutical sectors (community pharmacy, pharma companies, pharmaceutical education and research). For him, the twining between teaching and research represents the best response to challenges and community needs and ensure the highest quality of practicing and delivering health services. As a sense of responsibility towards pharmacy profession, he has launched few epidemiological and pharmacy practice projects to upscale the pharmacy profession and role of pharmacists. He has extended an arm in service to stakeholders and health authorities in Lebanon (MoPH, OPL, PHC, etc) to respond to surrounding challenges and crises threatening the pharmacy profession and community health as well.

Pharmacy needs to build sustained data and analytics capabilities that support evidence-based decision making and advocacy interventions that inform policy development. Improving capacity in data and intelligence across FIP and its member organisations, is essential to advance pharmacy world-wide. This event explores challenges and opportunities that maximise the use of data to generate evidence of impact across safe and effective use of medicines, pharmacy practice and the pharmacy workforce..

Aim
To describe approaches for delivering the required data and intelligence to generate evidence of impact for the profession and current and future policy: enablers and barriers that will support this through practical approaches.

Learning objectives:

1) Explain how health information systems can be strengthened;
2) Describe approaches to evidence generation;
3) List current enablers/opportunities and barriers for using pharmacy data and intelligence to their full potential;
4) Discuss how the pharmacy profession makes better use of data and intelligence.

Moderator:
- Christopher John, FIP Lead for Data and Intelligence FIP, UK

Panellists:
- Sallie Pearson, Professor of Health Systems Research UNSW Sydney, Australia
- Astrid Czock, FIP Global Lead for DG8: Working with others, CEO Qauliccare, Switzerland
- Saja A. Alnahar, Assistant Professor Yarmouk University, Jordan
- Hong Anh Chu, Technical Officer, WHO, Switzerland

Pharmacists around the world kept their doors open and lights on during the Covid19 Pandemic. We were our communities point of access and trust for their healthcare advice and needs.
Our ability to maintain and enhance our professional role in adversity was hugely challenging for pharmacists and their teams. How did we do it and what did we learn? What will Community Pharmacy look like in a Post Covid World?

Guest speaker: Daragh Connolly, Community Pharmacist, Irish Pharmacy Union, Ireland FIP Community Pharmacy Section Chair.

About Daragh Connolly:
I am a third-generation pharmacist with 25 years’ experience, predominantly but not exclusively, in community practice. Community practice is my joy and passion, I own and run my Community Pharmacy in Dungarvan Co. Waterford with a great team serving a great community. I am very fortunate that throughout my career I have met and collaborated with fantastic pharmacists here in Ireland and around the world to advocate and implement advancing our role to better serve our communities and our profession.
I was delighted to be asked to be lead author of the CPS Vision 2025 and in the spirit of collegiality and collaboration we have created a fantastic document to inspire peak practice of pharmacy around the world.

I believe every pharmacist in every setting should have the opportunity to practice to the best of their ability to improve the health of the people they serve. As we emerge from Covid19 and learn from our vital role in keeping quality healthcare accessible when others closed their doors we now practice at a most exciting and pivotal time.

In my spare time I love spending as much timeI enjoy long walks with my wife, kids and 2 golden retrievers. I love watching and following rugby and my ambition is to become a high handicap golfer.

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
- Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
- Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
- Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
- John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.

Learning objectives:
By the end of the session participants should be able to:
• Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
• Understand the main recommended vaccines for people living with cardiovascular diseases
• Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
- Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia

Panellists:
- Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina
- Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland
- John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA

Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.

By the end of the session participants should be able to:
• Understand dysbiosis and gut wellness
• Identify tips to manage abdominal pain
• Understand the role of diet in immunologic modulation
• Understand the use of probiotics for gut wellness

Moderator:
- Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India

Panelists:
- Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia
- Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal
- Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey
- Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey

Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.

By the end of the session participants should be able to:
• Understand dysbiosis and gut wellness
• Identify tips to manage abdominal pain
• Understand the role of diet in immunologic modulation
• Understand the use of probiotics for gut wellness

Moderator:
- Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India

Panelists:
- Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia
- Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal
- Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey
- Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey

Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.

By the end of the session participants should be able to:
• Understand dysbiosis and gut wellness
• Identify tips to manage abdominal pain
• Understand the role of diet in immunologic modulation
• Understand the use of probiotics for gut wellness

Moderator:
- Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India

Panelists:
- Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia
- Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal
- Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey
- Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey

This event will showcase how nations have coordinated pharmacy support for person-centred care in the fight against COVID-19 with a focus on strategy, policy and practice. Barriers and enablers to pharmacy’s involvement in the pandemic will be discussed as well as insights for countries wanting to advocate for pharmacy’s greater contribution in health systems. The future role of pharmacy in pandemics will be highlighted.

Aim
To describe current and future pharmacy practice in delivering person-centred care during the fight against COVID-19 and possible future pandemics.

Learning objectives:

1. List policy and professional enablers and barriers for developing pharmacy practice during the COVID-19 pandemic;
2. Give examples of pharmacy services used in the fight against COVID-19;
3. Describe approaches for advocating for pharmacy support in pandemics;
4. Predict the role of the pharmacist and their teams in future pandemics.

Moderators:
-Nadia Bukari, FIP Global Lead/Associate Professor, University College London FIP/UCL, UK
-Abby Kahaleh, PhD, MS, BPharm, MPH, FAACP, FIP Global Lead on Quality Assurance for Pharmacy Education, Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty, Roosevelt University, USA

Panelsits:
-Suzete Costa, PharmD, MPH, PhD Executive Director & Senior Research Director Institute for Evidence-Based Health (ISBE), Portugal
-Michael Ganio, Senior Director, Pharmacy Practice and Quality ASHP, USA
-Shepard Mhlaba, FIP Global Lead, FIP Workforce Development Hub, WDG2: Early career training strategy, Drug Information Pharmacist/Research Assistant, Drug and Toxicology Information Services (DATIS), Harare, Zimbabwe

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder that affects people of all ages. Pharmacists can play an important role in symptom management, referral to other healthcare professionals and provision of advice to improve quality of life. This event will provide an overview of the main roles pharmacists can have in supporting people living with IBS, from a community pharmacy perspective.

By the end of the session participants should be able to:
• Discuss the role of community pharmacists around IBS
• Understand the difference in symptoms between abdominal cramping pain and IBS
• Identify red flag symptoms for referral of IBS patients

Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica

Sesión IV: Bioequivalencia - Estudios de Disolución de Formas Farmacéuticas

Sesión en Español

 Este webinar tiene como objetivo presentar los conceptos:

• Aspectos teóricos de la disolución de APIs

o   Etapas

o   Modelos

• Disolutores

o   Aparatos I-IV y aplicaciones

• Aplicaciones de los Estudios de disolución comparativa
• Metodologías de disolución con cambio de pH
• Medios biorrelevantes y bicarbonato

Moderadora:
- Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil

Panelista:
- Pablo González, CEO Innovation and Biopharmaceutical Evaluation Center, Chile

Consumers throughout the world are increasingly looking to the internet to purchase their drugs. The worldwide pandemic has caused many consumers, who had not done so previously, to look to the internet for healthcare, healthcare information and medicinal products. However, at any given time, 95% of the roughly 35,000 online drug sellers worldwide operate illegally, in violation of laws and placing consumers at risk. Drugs purchased through an illegal drug seller on the internet may contain no drug, subtherapeutic levels of a drug, a completely different drug, or toxic chemicals. These websites will appear to be “pharmacies” or other “medical centres” providing credible health care, drug information and safe and approved medications, but are not and present risk to the unknowing consumer.

Regulators throughout the world are monitoring the level of nefarious drug sellers and “medical clinics” on the internet. Regulatory solutions to combat and remove the presence of these harmful vendors and sites have not been widely implemented. Public awareness is an important step, but also raising the awareness among healthcare providers, law makers and social media platforms.

Learning Objectives:
-To identify the level of illegal online drug sellers and bogus medical clinics on the internet and impact on the unsuspecting public
-To identify the barriers to overcome and better protect the public.
To identify programs and initiatives currently in place to combat misinformation, poor virtual care and falsified medication to enhance the safety and protect the internet consumer
-To encourage and support standards for virtual care.

Moderator:
-Ronald Guse, Chair FIP Regulators Forum - Canada
Panelists:
-Mike Isles,Director Alliance for Safe Online Pharmacy-EU-UK
-Justin Macy,Digital Health Senior Manager National Association of Boards of Pharmacy-USA
-Libby Baney,Senior Advisor to ASOP Global; Partner, Faegre Drinker LLP, Alliance for Safe on Pharmacy Global-USA

Overall Aim:
To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them provide better patient advice and self-care.

Learning objectives:
• Identify the sources of indoor air pollution and its increasing threat to health
• Understand the short- and long-term impact of indoor air pollution particularly on children
• Understand clinical, pharmacological, and non-pharmacological treatments including self-care measures to minimize the impact of air pollution on respiratory health
• Illustrate how advocacy can impact behavior change to support adoption of better self-care practices aimed at reducing health impact of air pollution.

Moderator:
- Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia

Facilitator:
- Nour Eltahla, FIP Projects Coordinator for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia

Panelists:
- Lidia Morawska, Director International Laboratory for Air Quality and Health (WHO CC for Air Quality and Health), Queensland University of Technology, Australia
- Gary WK Wong, Professor and honorary consultant, Department of Paediatrics, Chinese University of Hong Kong, Hong Kong
- Tyler Knowlton, Director of Communications, Communities, and Partnerships Plume Labs, France

The demand for travel health and travel medicine services is rapidly growing with the return levels of international travel. Patients are frequently turning to community pharmacies for advice on disease reduction and maintaining personal health whilst travelling. Pretravel preparation is important for many reasons one of which is supporting Global Health policies and strategies.

In some countries legislation has been devolved to allow pharmacists to prescribe medication and vaccinate travellers. However, this is not the situation globally and the many countries place restrictions on this type of pharmacy practice.

Learning objectives:
- To raise the awareness of pretravel consultation service that can be provided in a community setting without prescribing or vaccination.
- To identify over-the-counter products that can be supplied to support travellers visiting a pharmacy
- Compare and contrast classes of over-the-counter products for selected conditions and identify/select appropriate patients for their use.
- Showcase the collaborations with the International Institute of Travel Medicine through membership of ISTM and completion of Certificate of Health

Moderator:
- Daragh Connolly, President Community Pharmacy Section, Ireland

Panelists:
- Derek Evans, Pharmacist Specialist in Travel Medicine Evans Travel Health consultancy, UK
- Karl Hess, Director, Community Pharmacy Practice Innovations Department of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, California, USA
- Sheila Seed, Professor and Chair of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, USA
- Larry Goodyer, Professor of Pharmacy Practice, Leicester School of Pharmacy Faculty of Health and Life Sciences, De Montfort University, UK

The importance of good mental health and wellbeing has gained attention over the last decade due to an increased burden of disability and loss of quality of life associated with mental health conditions. Pharmacists have a significant role in the support and management of persons with mental health illnesses and in reducing the commonly associated stigma. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of mental health-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in mental health which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.

Attendees will learn about:

1. The role of pharmacists in the prevention, identification, care and management of mental health illnesses;
2. Challenges and opportunities for pharmacists in addressing mental health illnesses;
3. The knowledge and skills pharmacists need to acquire to support their role in mental health.

Moderator:
- Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, Portugal

Panelsits:
- Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
- Sarira El-Den, Senior Lecturer The University of Sydney School of Pharmacy, Australia
- Jiahui (Jeff) Dong, PharmD Candidate The University of North Carolina, Eshelman School of Pharmacy, United States
- Dalia Bajis, FIP Lead for provision and partnerships, Australia

The Universal Health Coverage (UHC) Competency Framework was published by WHO as a guide to progress towards building more holistic and integrated health systems. Critically, this includes human resources education and the implementation of Competency-Based Education (CBE) for healthcare workers to ensure adequate, and integrated, education and training.

WHO Universal Health Coverage Competency Framework: https://www.who.int/publications/i/item/9789240034686

Learning Objectives:

1. Overview of the principles and objectives of the WHO universal health coverage competency framework
2. Understand competency-based education and its role in developing the global healthcare workforce for UHC
3. Contextualize the UHC competency development guide to fulfil training needs - based on country of practice
4. Focus on pharmacy and pharmacy support workforce role in UHC

Moderator:
- Abigail Tan Ming Li, Staff training and the planning of continuing education topics. KK Women's and Children's Hospital, Singapore

Panelists:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, United Kingdom
- Siobhan Fitzpatrick, WHO technical officer WHO, Switzerland

This first event in the FIP 2022 series 'Food for thought: Pharmacists' role in health nutrition' aims to describe the basics of nutrition for pharmacists, and the role of pharmacists in providing nutrition services for better health outcomes, expanding from the 2021 FIP report "Nutrition and weight management services: A toolkit for pharmacists".

Moderator:
- Jaime Acosta, Community Pharmacist, Farmacia Acosta, Spain

Panellists:
- Joanna Harnett, Senior Lecturer, Sydney Pharmacy School, Australia
- Rúben Viegas, Practice Development Projects Coordinator, FIP, Portugal

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:

-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
-Understand the main recommended vaccines for people living with chronic respiratory diseases
-Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
-Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists - strategic policy The Pharmaceutical Society of Australia - Australia 

Panelists:
-Ema Paulino,  President  National Association of Pharmacies, Portugal (ANF), Portugal
-Fiona Mosgrove, General Practitioner NHS Grampian, UK
-Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain

Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.

By the end of the session participants should be able to:

-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated
-Understand the main recommended vaccines for people living with chronic respiratory diseases
-Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group

Moderator:
-Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists - strategic policy The Pharmaceutical Society of Australia - Australia 

Panelists:
-Ema Paulino,  President  National Association of Pharmacies, Portugal (ANF), Portugal
-Fiona Mosgrove, General Practitioner NHS Grampian, UK
-Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain

Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica

Sesión III: Bioequivalencia - Estudios de Solubilidad de Fármacos

Sesión en Español

Este webinar tiene como objetivo presentar los conceptos:

• Factores del API que determinan su solubilidad
• Factores del medio que determinan la solubilidad del API
• Metodologías

o   Método termodinámico

o   Método cinético

• Modificación tecnológica de la solubilidad de API

Moderadora:
-Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil

Panelista:
-Pablo González, CEO Innovation and Biopharmaceutical Evaluation Center, Chile

Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.

 FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.

This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.

In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the EMR.

Moderator:

- Samira Shammas, Bureau Liaison - EMR, FIP, Jordan

Co-Moderator & Facilitators :

- Meshkat Torkamanian, FIP - YPG Early Career Regional Supporter, Iran
- Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan
- Hamsa Hassan, FIP - YPG Early Career Regional Supporter, Egypt

Panellists:

- Akbar Abdollahiasl, Assistant Professor, Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran
- Saleh Hanash, Pharmapreneur/Founder of Agonist Consult, Agonist Consult, Jordan
- Ali Omeiat, Head of pharmacies and drug stores inspection section, Inspection and control department, Jordan Food & Drug Administration, Jordan
- Ahmed Hamdan Aljedai, Assistant Deputy Minister for Medical support Services, Ministry of Health, Saudi Arabia

This event will discuss pharmacists’ roles in diabetes prevention, screening and management by showcasing best practices in pharmaceutical care, identifying needs and priorities of pharmacists, digital health applications, new trends and practices across Africa. According to WHO, diabetes in the region is a serious, chronic, and costly disease that is estimated to rise to 23.9 million cases by 2030, and up to 15% of adults aged 25 to 64 have diabetes in the African region. s. Pharmacists are uniquely positioned to provide a wide array of services to prevent, identify and manage both type 1 and type 2 diabetes as well as support the care provided by other members of the healthcare team. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of diabetes.

Learning objectives:

• Improve knowledge of pharmacists by exploring the role of pharmacists in the prevention, screening and management of diabetes within the African region;
• Showcase emerging digital health trends, new applications for patients and innovative pharmaceutical services delivery for diabetes within the African region;
• Identify the needs and priorities of pharmacists in the prevention and management of diabetes within the African region.

Moderator:
- Prosper Hiag, President African Pharmaceutical Forum, Cameroon

Guests:
- Danielle Munene, Head of Consulting African Health Business, Kenya
- Imraan Bismilla, Head of Pharmacy Centre for Diabetes and Endocrinology in South Africa, South Africa
- Mohamed Yacine Achouri, President of the scientific communication Fédération Algérienne de Pharmacie, Algeria
- Khadir Sarra, Pharmacy resident, FIP YPG remote intern, Algeria
- Gonçalo Sousa Pinto, FIP Lead for practice development and transformation, Spain

Facilitators:
-Nilhan Uzman, Lead for Education and Primary Health Policies FIP, Turkey
-Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria

This event will discuss pharmacists’ roles in diabetes prevention, screening and management by showcasing best practices in pharmaceutical care, identifying needs and priorities of pharmacists, digital health applications, new trends and practices across Africa. According to WHO, diabetes in the region is a serious, chronic, and costly disease that is estimated to rise to 23.9 million cases by 2030, and up to 15% of adults aged 25 to 64 have diabetes in the African region. s. Pharmacists are uniquely positioned to provide a wide array of services to prevent, identify and manage both type 1 and type 2 diabetes as well as support the care provided by other members of the healthcare team. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of diabetes.

Learning objectives:

• Improve knowledge of pharmacists by exploring the role of pharmacists in the prevention, screening and management of diabetes within the African region;
• Showcase emerging digital health trends, new applications for patients and innovative pharmaceutical services delivery for diabetes within the African region;
• Identify the needs and priorities of pharmacists in the prevention and management of diabetes within the African region.

Moderator:
- Prosper Hiag, President African Pharmaceutical Forum, Cameroon

Guests:
- Danielle Munene, Head of Consulting African Health Business, Kenya
- Imraan Bismilla, Head of Pharmacy Centre for Diabetes and Endocrinology in South Africa, South Africa
- Mohamed Yacine Achouri, President of the scientific communication Fédération Algérienne de Pharmacie, Algeria
- Khadir Sarra, Pharmacy resident, FIP YPG remote intern, Algeria
- Gonçalo Sousa Pinto, FIP Lead for practice development and transformation, Spain

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica

Sesión II: Bioequivalencia - Sistema de Clasificación Biofarmacéutica: Fundamentos y aplicaciones a las bioexenciones

Este webinar tiene como objetivo presentar los conceptos:

• Definiciones e hipótesis
• Fundamentos del modelo
• Números adimensionales
• Clases y factores limitantes de la absorción

Moderadora:
-Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil

Panelista:
-Pablo González, CEO Innovation and Biopharmaceutical Evaluation Center, Chile

This event is to update pharmacy professionals about managing workforce demand in a pandemic – now and in future. Case studies will be presented from countries across the globe. These will address how we ensure continuity of workforce supply during this and future pandemics, how can we reduce demand on the workforce and the role of healthcare regulators play.

Aim
To present to attendees approaches for managing workforce demand in a pandemic.

Learning objectives
1. Discuss how continuity of workforce supply can be managed during pandemics
2. Discuss how demand for the pharmaceutical workforce can be reduced during pandemics
3. Describe the impact of COVID-19 pandemic on the pharmacy workforce
4. Explain how pharmacists can be prepared for the role of vaccinator.

Moderator:
- Christopher John, FIP Lead for Data and Intelligence, FIP, UK

Panelists:
- Mariet Eksteen, Global Lead for FIP Development Goal 7: Advancing Integrated Services; Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa
- Chima Amadi, Global Lead, FIP Development Goal 13 (Workforce Policy Formation); Education and Training Personnel Pharmacists’ Council Nigeria, Nigeria
- Rula Darwish, Exco committee FIP academic section WDG9 Lead; Professor School of Pharmacy/ The University of Jordan, CPD Chair in JPA,  Jordan
- Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services; Lecturer University of Bremen, Germany

The Pharmacy Education Journal (PEJ) continues to publish peer-reviewed manuscripts in the general scope of practise domain of pharmacy education (at all stages) and workforce development research and evaluation. PEJ is planning for widening scope by introducing educationally-related short, rapid response articles targeting non-traditional authors (non-academics) in Practice and Science sectors. PEJ is a key global dissemination route.

Event outcomes:

1 Showcase what did PEJ achieve during 20 years, how it was done and present the new plans.
2 Highlight the importance of publishing in the pharmaceutical workforce and education field.
3 Explain the steps from submission to publication: what happens behind the screen and who does it and provide some tips for authors.

Moderators:
- Marwan Akel, Projects Manager – Workforce development, evidence & impact Journal Editor – PEJ, FIP, Lebanon
- Sherly Meilianti, FIP Data and Intelligence Specialist, FIP, Indonesia

Panelists:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, UK
- Lilian M. Azzopardi, Prof. of Pharmacy Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta President, European Association of Faculties of Pharmacy, Malta
- Judilynn L. Niedo-Solidum, Prof. at University of the Philippines Manila College of Pharmacy, Philippines
- Rudi Hendra, Associate professor Indonesian Pharmacists Association, Indonesia
- Shane Desselle, RPh, PhD, FAPhA Professor of Social and Behavioral Pharmacy Touro University California College of Pharmacy, USA
- Jennifer Marriott, Adjunct Associate Professor, Australia

Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.

FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.

This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.

In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in Africa.

Moderator:
-Prosper Hiag, President, African Pharmaceutical Forum, Cameroon

Facilitators:
-Anyango Esther, FIP - YPG Early Career Regional Supporter Africa Health Business (AHB), Kenya
-Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan

Panelists:
-KWABENA ASANTE OFFEI, Vice-President Pharmaceutical Society of Ghana (PSGH), Ghana
-Vigil Edward Prah-Ashun, Head of Intelligence Food and Drugs Authority, Ghana
-Redouane Soualmi, Secretary general Algerian Pharmaceutical Federation, Algeria
-Brent Sin Hidge, Hospital Pharmacist / Project Co-ordinator Netcare Blaauwberg Hospital, Cape Town, South Africa
-Mariet J Eksteen, Professional Development and Support Pharmaceutical Society of South Africa, South Africa

Constipation is a common symptom pharmacists encounter in daily practice. It is often a self-limiting symptom that can be adequately managed in the community through the use of non-prescription medicines, as well as dietary and lifestyle measures. This event will explore how community pharmacists may support the management of constipation and empower individuals for optimal self-care.

By the end of the session participants should be able to:
• Understand the role of pharmacists in managing constipation in the community
• Understand the influence of fibre, exercise, and fluids in constipation
• Explore the complications of constipation medicines, especially in older adults

Moderator:

- Marwan Akel, FIP Projects Manager - Workforce development, evidence & impact, Lebanon

Panellists:

- Safwan Jihan, Assistant Dean, Lebanese International University / School of Pharmacy, Lebanon 
- Madisch, Ahmed, Senior Consultant and Head, Center of Gastroenterology Bethanien, Germany 
- João Rafael Gonçalves, Community pharmacist, Portugal

Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica

Sesión I: Bioequivalencia

Sesión en Español

Este webinar tiene como objetivo presentar los conceptos:

• Medicamentos genéricos
• Definiciones
• Qué es bioequivalencia?
• Tipos de estudios
• Estudios farmacocinéticos:

o Diseños
o Consideraciones clínicas, analíticas y estadísticas

• Casos especiales

Moderadora:
- Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil

Panelista:
- Pablo González, CEO, Innovation and Biopharmaceutical Evaluation Center, Chile

In order to ensure pharmacists maintain currency and quality in their practice, mandatory continuing professional development (CPD) programmes have been implemented by regulatory authorities as part of the licence renewal requirements for continuing practice. This webinar will provide information on the countries having a mandatory CPD programme, the various types of programmes, the regulations and the overall value and monitoring. In addition, information will be provided on CPD for specialized areas of practice, as part of returning to practice and some new concepts to insure currency and quality.

The attendees will learn:
-the overall importance of a mandated CPD programme from a quality assurance and patient safety perspective ;
-the variations of CPD programmes currently in place in various countries;
-the legislation/regulations in place mandating a CPD programme to maintain currency and enhance competence, quality assurance and patient safety;  
-recertification programs for "specialization" and "return to practice"; and,
-other innovative way to insure quality and currency of pharmacists.

Moderator:
- Brett Simmonds, Chair Pharmacy Board of Australia, Australia

Panelists:
- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, France
- Michael Pead, Chief Executive Pharmacy Council of New Zealand, New Zealand
- Trish Farrelly, Manager Registration and Competence Assurance, Pharmacy Council of New Zealand, New Zealand
- Joe R. Anderson, Assistant Dean for Curricular Affairs and Associate Professor of Pharmacy Practice and Administrative Sciences, The University of New Mexico College of Pharmacy, USA

Gastrointestinal health and digestive wellness can be influenced by several lifestyle factors, including diet and stress, and using certain types of medicines. It is important for pharmacists to consider these factors when interacting with patients who present with such symptoms. Different non-prescription medicines are available to treat symptoms related to GI complaints and digestive wellness, rendering pharmacies key access points for trusted advice and access to self-care products which can provide relief and care to affected individuals. This event marks the World Digestive Wellness Day (29 May).

By the end of the session participants should be able to:
• Understand the role of pharmacists in providing advice on digestive wellness
• Understand the relationship between gut wellness and immunity
• Identify practical ways to support better digestive wellness in the community

This event discusses current evidence for the impact of the pharmaceutical workforce, pharmacy practice and pharmaceutical science.  It discusses and evidence-based approach and identifies challenges and opportunities for generating evidence that will advance the profession.

Aim
To showcase how data and intelligence can be used to provide evidence of impact of pharmaceutical practice, science and education/workforce.

Learning objectives

• Discuss approaches to securing evidence for the impact of the pharmaceutical workforce and pharmaceutical services.
• Discuss strategies and programmes in place to enable timely access to safe, effective and affordable medicines.
• Identify challenges and opportunities for generating evidence of impact.

Moderator:
- Christopher John, FIP Lead for Data and Intelligence, UK

Panellist: 

- Noe Garin Escriva, Hospital Pharmacist, Hospital de la Santa Creu i Sant Pau, Spain
- Harriet Rachel Kagoya, Uganda
- Safa Damiati, Assistant Professor, King Abdulaziz University, Suadi Arabia
- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia
- Hilwan Yuda Teruna, Vice President, Indonesian Pharmacists Association, Indonesia

The FIP Hospital Pharmacy Section (HPS) has set out to develop its strategy for the next 5 years. In early 2022, the FIP HPS developed a survey to identify how the FIP HPS can assist FIP Vision/Mission and FIP Development Goals. This survey was sent to FIP Hospital Pharmacy Executive Committee members, Chairs of Committees/Observers, Past Executive Committee members, Hospital Pharmacy Member organisations and regional forums. Results of the survey will be presented with a discussion on the FIP HPS strategy.

Learning objectives:
- To know the results of the FIP HPS strategy survey
- To identify priorities areas for the FIP HPS over the next 5 years
- To participate in the future direction of the FIP HPS

Chair:
-Jonathan Penm, Secretary, FIP Hospital Pharmacy Section, Senior Lecturer The University of Sydney- Australia

Panelist:
-Robert Moss, President, FIP Hospital Pharmacy Section- the Netherlands

With the COVID-19 pandemic, effective use of educational technologies has become essential. Many different aspects of technology have been introduced or further expanded, including remote experiential learning or simulations for virtual patient care. At the same time, artificial intelligence enabled faculties to accelerate and advance research and clinical care in the pharmaceutical sciences and clinical pharmacy practice.

Introduction and implementation of any technology-enabled education and training includes many success factors such as technology literacy amongst educators and students. To enhance technology-enabled pharmaceutical education, this digital event will outline good practices and engage participants in identifying a SWOT (Strengths, Weaknesses, Opportunities, and Threats) of technology and AI use in education.

At the end of this session, participants will: 
1.Learn about current and future good practices about the educational technologies used in higher/pharmaceutical education
2.Contribute to the development of a SWOT in using Technology & AI in pharmaceutical education
3.Identify ways to enhance quality of education and academic capacity by utilizing technology and AI in pharmaceutical education

Co-chairs:
- Lilian Azzopardi, Dean Department of Pharmacy, University of Malta, Malta
- Jaime Acosta Gómez, FIP Community Pharmacy Section, FIP Technology Forum co-chair, FIP COVID19 Expert Advisory Group member; Community Pharmacist and pharmacy owner Farmacia Acosta, Spain

Panelists:
-Mia Sivén, Vice-Dean University of Helsinki, Finland
-Francesca Wirth, Senior Lecturer University of Malta, Malta
-Daniel Malone, Pharmacy Course Director Monash University, Australia

Facilitator:
-Aysu Selcuk, FIP AIM Advisory Committee Member, FIP Education and Primary Health Care Policies Specialist, Turkey

This event will discuss the role of community pharmacists in promoting oral health and the links between oral health and other non-communicable diseases. Also, the event will address the needs for additional training, interprofessional education and collaborative practice models between dentistry and pharmacy. Key interventions by community pharmacists in oral health care from different parts of the world will be presented.

Aim: To discuss the role of pharmacists in oral health, describe how pharmacists’ interventions in oral health can contribute to the prevention of non-communicable diseases, and explore interprofessional education and collaborative practice models between dentistry and pharmacy.

Learning objectives:
1. Understand the importance of oral health in the prevention of non-communicable diseases (NCD), such as cardiovascular and respiratory diseases, cancer and diabetes;
2. Explore the role of community pharmacists in promoting oral health care;
3. Discuss the need for oral health care training and education resources that support pharmacists deliver improved and responsive oral health care interventions;
4. Explore interprofessional collaborative practice models between dentists and pharmacists.

This webinar will announce a new partnership between FIP and Curriculo Solutions to introduce our members to the newly FIP Seal-awarded programme: “Pharmacists for the Future Programme” (PFP).

Curriculo is a UK based training company specialising in leadership and management skills development and career management. They work across various sectors including corporate, health care, education and sport.

The PFP focuses on the development of personal, social and professional skills and provides a strong foundation in the development of key leadership capabilities. The programme aligns with Development Goal 9: Continuing professional development strategies and addresses a skill gap that has been identified by members in leadership development.

During the event, FIP and Curriculo will:

• announce the new partnership for the FIP-sealed PFP.
• describe aspects of the provision and partnerships programme at FIP.
• describe the PFP and hear from previous participants in the programme through the sharing of testimonials.
• describe how FIP members can benefit from this programme.

This event is to update pharmacy professionals about the range of therapeutic options currently available for COVID-19. It will take an evidence-based approach and also look at future development of therapeutic agents.

Aim
To update attendees on the latest therapeutic advances against COVID-19

Learning objectives
1. Explain which medicines are available that target the virus or provide symptom control
2. Discuss which medicines will be effective against new variants.
3. Describe what other medicines are available and what is the evidence for them.
4. List medicines in the pipeline for treating COVID-19

Moderator:
-Christopher John, FIP Lead for Data and Intelligence, FIP - UK

Panelists:
-Syed Shahzad Hasan, Senior Research Fellow University of Huddersfield-UK
-Trevor Jones, Visiting Professor King’s College London - UK

Early feasibility clinical study was performed to assess the feasibility and tolerability of syringe pump-driven, constant rate (20µl/s), 1-20cP, 5 and 10ml subcutaneous placebo injections to the thigh (5ml only) and abdomen in 32 healthy adults. Endpoints include injection feasibility, depot location, pressure, subject pain tolerability/acceptability and the corresponding tissue effects.

Session Outline:

• Demonstrate the feasibility and broad acceptability of subcutaneous injections up to 10ml and 20cP administered without a permeation enhancer

• Determine if injection site tissue effects are visible and transient as well as the impact of injection site, volume and viscosity on these patterns

• Explore the relationship between subjects’ pain/acceptability and the injection site, volume and/or viscosity

Moderator

- Mathew Cherian, Consultant, Executive Committee Member (IPS), USA

Panellist 

- Wendy D Woodley, Staff Scientist II, Translational & Clinical Sciences, BD Technologies and Innovation, USA

Around the world, community pharmacies play an increasingly consolidated role in vaccination. During the pandemic, pharmacies’ accessibility made them a convenient place for vaccination against COVID-19 in several countries, increasing vaccination coverage and helping achieve herd immunity. As the world slowly begins to emerge from the pandemic, this event will discuss the role of community pharmacies in COVID-19 booster vaccination, and their challenges in vaccine supply logistics and cold storage solutions, particularly in a post-pandemic scenario. Key interventions by community pharmacists in vaccine supply logistics linked to COVID-19 from different parts of the world will be presented.

Learning objectives:

1. Understand the supply chain and distribution process of COVID-19 vaccines from manufacturer to hospitals, community pharmacies, and the public;

2. Explore the role of community pharmacies in vaccine supply logistics for COVID-19;

3. Discuss the challenges of COVID-19 booster vaccination supply logistics and cold storage solutions in community pharmacies, particularly in a post-pandemic scenario;

4. Explore supply models that involve community pharmacies contributing to population vaccination coverage in a post-pandemic scenario.

Moderator:
- Catherine Duggan, Chief Executive Officer FIP, the Netherlands

Panellists:
- Vibhu Paudyal, Associate Professor in Clinical Pharmacy University of Birmingham, UK
- Ronald T. Piervincenzi, Ph.D., Chief Executive Officer USP, USA
- Loganathan Fahrni, Senior lecturer and pharmacist Universiti Teknologi MARA, Malaysia

The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.

Learning objectives:

1. To identify the current role of the pharmacist in tetanus, diphtheria, acellular pertussis booster, COVID vaccination, and meningococcal meningitis vaccination.
2. To explore needs, drivers, and barriers for expanding that role in countries that have regulated pharmacy-based vaccination services.
3. To give examples from countries with pharmacy-based vaccination services  in advocating a broader role for pharmacists in vaccination

Moderators:

- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education, University College London, United Kingdom

- Manjiri Gharat, FIP Vice-President, India 

Panellists:

- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, French Chamber of Pharmacists, France

- Zhi Shan Sujata, Pharmacist, Malaysian Pharmacists Society, Malaysia

-  Sham Moodley, Pharmacist,  Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc, South Africa

- Zeid Kilani, President, Jordan Pharmacists Association, Jordan

- Mas Rahman Roestan, Operational Director of PT Biofarma and Expert Council of Indonesian Pharmacists Association, Indonesian Pharmacists Association, Indonesia

- Irma Beatriz Caponi, Farmacéutica, COFA, Argentina

Facilitators & Speakers:

- Christopher John, FIP Lead for Data and Intelligence, UK 

- Zheng Kang Lum, PhD candidate, National University of Singapore, Singapore

- Allie Jo Shipman, Director, State Policy, National Alliance of State Pharmacy Associations, USA

- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia

This webinar is the first of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will introduce:

- The needs, goals and principles of precision medicine

- Examples of current implementation across disease categories

- Safety aspects and challenges

- Limitations of current approaches and needs for development

At the end of this session, participants will: 

1. Understand the goals of precision medicine
2. Be familiar with some examples of its implementation
3. Be aware of current limitations and remaining challenges

Co-Chairs:

- Donnacha Fitzgerald, FIP Technology Forum member, Predoctoral Fellow, The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital, Germany
- Stephanie Huang, Associate Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota, USA

Panellists:

- Ejner Moltzen, Chair, International Consortium for Personalized Medicine, Denmark
- Mark Dunnenberger, Director, Pharmacogenomics Center for Personalized Medicine NorthShore University HealthSystem, USA

Over the past 2 decades, virtual education evolved as a new pedagogy within education. Following the experience from the unexpected drastic shift to remote learning and virtual education as a result of the COVID-19 pandemic, educators are faced with dilemmas of how to strike a balance between face-to-face modalities and the virtual platform. Remote learning and virtual education provide opportunities and leadership to develop hybrid models of teaching is now being considered. The webinar will seek to expose experiences and share examples of such opportunities and how to lead faculty towards incorporating the virtual education while ensuring quality education.

The participants who join the webinar will;
• Address assessment of quality of virtual education at the schools of pharmacy
• Reflect on the extent of remote learning after COVID-19 in pharmacy education
• Discuss approaches towards the development of hybrid education in pharmacy schools

Chairs:
-Pierre Moreau, FIP AIM Chair, Dean Kuwait University, Kuwait
-Lilian Azzopardi, FIP AIM Advisory Committee Member, Dean Department of Pharmacy, University of Malta, Malta
-Hanan Refaat, FIP AIM Advisory Committee member, Dean Future University in Egypt, Egypt

Panelists:
-Seif El Hadidi, FIP AIM member, Lecturer in Clinical Pharmacy, Future University in Egypt, Egypt
-Brian Hemstreet, FIP AIM working group member, Associate Dean for Student Affairs and Professor University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
- Jennifer Pham, Clinical Associate Professor, Clinical Pharmacist – Neonatal / Pediatrics, University of Illinois at Chicago College of Pharmacy, USA
- Alan Lau, Professor and Director, International Clinical Pharmacy Education University of Illinois at Chicago College of Pharmacy, USA

Facilitator:
-Ozge Ozer, Educational Partnership Manager, Turkey

This is the COVID-19 programme initiator and will set the scene: why this programme; main outcomes; FIP advocacy role. It aligns with 800 days since pandemic and will launch SustainabilityRx website/ Visualisation (FIP’s response to COVID-19) with a focus on pandemic preparedness.


Learning objectives
1. Describe the functionality of the SustainabilityRx website
2. Outline the current COVID-19 situation from the perspectives of practice, science and workforce/education;
3. Consider steps that can be taken to prepare for future pandemics.

Moderators:
- Christopher John, FIP Lead for Data and Intelligence, FIP, UK
- Dr Lina Bader/Dr Sherly Meilianti FIP Lead for Workforce Transformation/FIP Data and Intelligence Specialist, FIP-Saudi Arabia

Panelists:
- Dr Hoai-An Truong, Professor and Director of Public Health, School of Pharmacy & Health Professions, University of Maryland Eastern Shore, USA
- Dr John Grabenstein, Member of FIP COVID-19 Expert Advisory Group, President Vaccine Dynamics SP, USA
- Prof. Trevor Jones, Visiting Professor King’s College London, UK
- Dr Ally Dering-Anderson, Current member of the FIP COVID-19 Expert Advisory Groupm, Clinical Associate Professor in the Department of Pharmacy Practice & Science University of Nebraska College of Pharmacy, USA
- Shaun Gleason, FIP Hub DG1 Lead, Member of the COVID-19 Expert Advisory Group, Assistant Dean for Distance Degrees and Programs; Associate Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus, USA

Epilepsy is a disorder that afflicts approximately 50 million people worldwide and the WHO has declared epilepsy as a public health imperative. Medications are the mainstay of treating epilepsy, so pharmacist have great role to play in improving the care of people with epilepsy. This Webinar will explore the findings of the recent WHO report on epilepsy, describe ways that pharmacists can be involved in caring for patients with epilepsy, consider advances in new medications, and discuss the challenges of access to medications for many people worldwide.

Learning Objectives:
1. Identify the main barriers to appropriate care of patients with epilepsy as described in the 2019 WHO report on epilepsy.
2. Describe ways that pharmacists can improve the care of patients with epilepsy.
3. Incorporate new antiseizure medications into treatment regimens for epilepsy.
4. Take steps to improve patient access to good quality seizure medications.

Moderator:
-Filipa Alves da Costa, ExCo member of the FIP Social and Administrative Pharmacy Section, Portugal

Panelists:
-Timothy Welty PharmD, College of Pharmacy and Health Sciences Drake University Des Moines, Iowa, USA
-McKenzie Grinalds, PharmD School of Pharmacy Cedarville University Cedarville, Ohio, USA
-Thanarat Suansanae PharmD, School of Pharmacy, Mahidol University Bangkok, Thailand
-Melody Ryan, Professor, University of Kentucky, USA

Approximately 90 percent of prescriptions in the US are generics that often are the product of an intricate global supply chain. The Office of Generic Drugs (OGD) is involved in efforts to advance the international harmonization of scientific, technical and regulatory standards for generic drug development. OGD continues global efforts with a focus on prioritizing future topics for generic harmonization that will include more complex generic drugs. The envisioned outcome of these global efforts is reduced time and cost of product development, consequently improving patient access to more affordable medicines. OGD Global Affairs identifies opportunities and challenges as those national regulations are being developed and implemented positioning regulators proactively on the path of convergence.

Learning Objectives:
1) FDA’s views on global harmonization of regulatory process for generic drugs
2) Identifying opportunities and challenges in arriving at harmonized processes globally.

Moderators:
-Dr Mathew Cherian, Executive Committee Member, Industrial Pharmacy Section, Consultant, USA
-Mr Desai Kaushik , Associate ExCo Member, Industrial Pharmacy Section (FIP), Secretary General, International Pharmaceutical Excipient Council of India, India

Panelist:
-Sarah Ibrahim, Director CDER, FDA, USA

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:
- Dr Samira Shammas, FIP Vice president, Jordan
- Jorge Batista, Portuguese Pharmaceutical Society, Portugal

Panelists:
- Dr Nadia Al Mazrouei, President, EMRO Pharm Forum, UAE
- Dr Pascale Salameh, President, Lebanese Order of Pharmacists, Lebanon
- Dr Maha al Jaghbeer, Director of Laboratories directorate, Jordan Food and Drug Administration, Jordan
- Dr Dixon Thomas, Associate Professor - Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University, UAE

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines. 

Learning objectives:

- Identify drivers and barriers related to the regulatory landscape of vaccination in the region

- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination

- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment.

Moderators:

- Manjiri Gharat, FIP Vice President, India
- Al Carter, Executive Director, National Association of Boards of Pharmacy, USA

Panellists:

- Tisara De Silva, President, Pharmaceutical Society of Sri Lanka, Sri Lanka
- Rao V. S. V. Vadlamudi, Professional Secretary, SEARPharm Forum, India
- Nurul Pariang, President, Indonesian Pharmacists Association, Indonesia
- Pramod Yeole, Acting President, Pharmacy Council of India, India

Ongoing learning and professional development are key to components of every occupation. This is especially true for pharmacy technicians working in a constantly-evolving practice landscape. This session will address professional development and advanced training for pharmacy technicians across the world.

Learning Objectives:
● Recognize strategies for continuous learning and professional development
● Identify professional development opportunities designed for pharmacy technicians
● Describe advanced training progams for pharmacy technicians

Moderators: 

- Ryan Burke, Director of Professional Affairs, Pharmacy Technician Certification Board, United States

Panelists:

- Nichole Foster, Program Director, Pharmacy Technician Training Program, Vanderbilt Medical Center, United States

- Peter Karegwa Mwangi, National Chairman, Kenya National Union of Pharmaceutical Technologists, Kenya

- Katherine Watkinson, Branch Liaison Executive, Association of Pharmacy Technicians, UK

Español

Para abogar por una implementación más amplia y armonizada del Sistema de Clasificación de Biofarmacéuticos (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la concientización sobre esta vía regulatoria basada en la ciencia diseñada para acelerar la aprobación del mercado de medicamentos genéricos seguros y efectivos. La tercera parte de esta serie de seminarios web diseñada específicamente para la región de América Latina desde la perspectiva de las agencias reguladoras sobre cómo se está implementando la legislación de bioequivalencia. Los expertos abordarán la base legislativa de las regulaciones de bioequivalencia y discutirán las oportunidades de armonización dentro de la región.

Sesión en Español con slides en inglés

Este webinar tiene como objetivo:

• • Presentar la legislación de Bioequivalencia de México, Colombia y Perú.
• • Alinear cómo las empresas deben establecer los requisitos del BSC.
• • Compartir el conocimiento regulatorio del BSC en la región.

Moderadora:

Talita Ferreira, Coordinadora de Proyectos de bioequivalencia en Latinoamérica, FIP, Brazil

Panelistas:
-Zulema Rodríguez Martinez, Coordinador del área de Bioequivalencia, Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris), México
-Diego Alejandro Gutierrez Triana, Director de medicamentos y productos biológicos, Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia
-David Salirrosas Llanos, Especialista en evaluación sanitaria de medicamentos, Dirección General de Medicamentos (DIGEMID), Perú

Portugués

Para defender uma implementação mais ampla e harmonizada do sistema de classificação de produtos biofarmacêuticos (BCS) em países latino-americanos, a FIP está apoiando os líderes regionais na conscientização para esta via regulatória com base científica projetada para acelerar a aprovação do mercado de medicamentos genéricos seguros e eficazes. A terceira parte desta série de webinars projetada especificamente para a região da América Latina sob a perspectiva das agências regulatórias como está sendo implementada as legislações de bioequivalências. Os especialistas irão abordar a base legislativa dos regulamentos de bioequivalência e discutir as oportunidades de harmonização dentro da região.

Sessão em Espanhol com slides em Inglês

Este webinar tem como objetivos:

• Apresentar as legislações de Bioequivalência do México, Colômbia e Peru.
• Alinhar como as empresas devem estabelecer os requisitos de BSC.
• Compartilhar o conhecimento regulatório de BSC na região.

Moderadora:

Talita Ferreira, Coordenadora do Projeto Bioequivalência da América Latina, FIP, Brasil

Panelistas:
-Zulema Rodríguez Martinez, Coordenadora da área de Bioequivalência, Comissão Federal de Proteção contra Riscos Sanitários (Cofepris), México 
-Diego Alejandro Gutierrez Triana, Diretor de medicamentos e produtos biológicos, Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colômbia
-David Salirrosas Llanos, Especialista em avaliação sanitária de Medicamentos, Direção Geral de Medicamentos (DIGIMED), Perú

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:

- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment.

Co-moderators:

- Jocelyn Chaibva, Vice president, African Pharmaceutical Forum, Zimbabwe
- Ronald Guse, Chair FIP Regulators Forum, Canada

Panellists:

- Samuel Adekola, Immediate past national chairman & the executive secretary/ program director of the ACPN foundation. Nigeria
- Djamila Reis, CEO, Association of Pharmacists from Portuguese-Speaking Countries, Cape Verde
- Portifa Mwendera, President, Pharmaceutical Society of Zimbabwe, Zimbabwe
- Lucas Nyabero, Interim CEO, Pharmaceutical Society of Kenya, Kenya
- Franck Nana, President, National Council of Pharmacists, Cameroon
- Amath Niang, President, Ordre des Pharmaciens du Sénégal, Sénégal
- Imoiboho Williams, Project Manager, Adverse Events Following Immunization Surveillance Institute of Human Virology, Nigeria
- Redouane Soualmi, Chairperson of External Relations, Algerian Pharmacy Federation, Algeria
- Ezinne Onwuekwe, Vaccine Programme Coordinator, Africa CDC, Ethiopia

Dans de nombreux pays, les taux de couverture vaccinale sont sous-optimaux et les services de vaccination sont essentiellement axés sur l'enfance.

Les objectifs visant à développer les parcours de vaccination consistent notamment à disposer de points de vaccination plus nombreux et facilement accessibles, d'un plus grand nombre de professionnels capables de fournir le service à un plus grand nombre de personnes et d'offrir des conseils sur les vaccins fondés sur des données probantes.

Cet événement permettra de discuter des moteurs et des obstacles à la compréhension interprofessionnelle, à la coopération et au partage des tâches dans le domaine de la vaccination dans la région, ainsi que de l'autorité réglementaire accordée aux différents professionnels de la santé pour prescrire et/ou administrer les vaccins.  

Objectifs d'apprentissage :

•       Identifier les moteurs et les obstacles liés au paysage réglementaire de la vaccination dans la région. 

•       Découvrez des exemples de bonnes pratiques en matière de coopération interprofessionnelle et de partage des tâches impliquant des pharmaciens dans le domaine de la vaccination. 

•       Explorer les plans pour passer d'une réponse pandémique à une réponse endémique dans la région, y compris le rôle du pharmacien dans la vaccination, et dans les soins et le traitement des patients. 

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:

- Lars-Åke Söderlund, FIP Vice President, Sweden
- Ronald Guse, Chair of FIP Regulators Forum, Canada

Panelists:
- Michał Byliniak, Vice president, Polish Pharmaceutical Chamber, Poland
- Alain Delgutte, National Board Member, French Chamber of Pharmacists
- Inga Lilý Gunnarsdóttir, President, Pharmaceutical Society of Iceland, Iceland
- Jean-Pierre Michel, Member, European Union of Geriatric Medicine Society. European Interprofessional Council on Ageing, Switzerland
- Ema Paulino, President, National Association of Pharmacies, and member of the National Vaccine Advisory Committee, Portugal
- Roberto Tobia, President, Pharmaceutical Group of the European Union, Italy
- Mariano Votta, President, Active Citizenship Network, Italy

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:
- Magaly Rodríguez de Bittner, Vice president, Pharmaceutical Forum of the Americas, USA
- Anastasia Shiamptanis, Registrar, New Brunswick College of Pharmacists, Canada

Speakers:
- Bertrand Bolduc, President, Order of Pharmacists of Quebec, Canada
- Josélia da Silva Frade, Advisor on Professional Affairs to the president, Federal Council of Pharmacy, Brazil
- Eduardo Savio, President, Pharmaceutical Forum of the Americas, Uruguay
- Sofía Segura, Professor, University of Costa Rica, Costa Rica
- L. J. Tan, Chief Policy and Partnerships Officer, Immunize.org, USA
- Abraham S. Weekes, Council Member, Caribbean Association of Pharmacists, St. Lucia

En muchos países, las tasas de cobertura de vacunación no son óptimas, y los servicios de vacunación se centran principalmente en la infancia. Los objetivos para ampliar las vías de acceso a la vacunación incluyen disponer de más puntos de vacunación de fácil acceso, más profesionales que puedan prestar el servicio a un mayor número de personas y ofrecer asesoramiento basado en la evidencia sobre las vacunas. En este evento se debatirán los factores que impulsan y obstaculizan el entendimiento interprofesional, la cooperación y el reparto de tareas en el ámbito de la vacunación en la región, así como la autoridad normativa concedida a los distintos profesionales sanitarios para prescribir y/o administrar vacunas. 

Objetivos de aprendizaje:

- Identificar los impulsores y las barreras relacionadas con el panorama normativo de la vacunación en la región

- Conocer ejemplos de buenas prácticas en materia de cooperación interprofesional y de reparto de tareas con la participación de los farmacéuticos en el ámbito de la vacunación

- Explorar los planes para pasar de una respuesta pandémica a una endémica en la región, incluyendo el papel del farmacéutico en la vacunación, y en el cuidado y tratamiento de los pacientes.

In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.

Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment

Moderators:
- Parisa Aslani, FIP Vice President, FIP, Australia
- Ron Guse, Chair FIP Regulators Forum, FIP, Canada

Panelists:
- Amrahi Buang, President, Malaysian Pharmacists Society, Malaysia
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia
- Michael Moore AM PhD, Chair of the WFPHA Global Taskforce on Immunization Adjunct Professor University of Canberra, Australia
- Tony Nelson, Chair of the Steering Committee, Immunisation Partnership Asia Pacific, Hong Kong
- Andi Shirtcliffe, Clinical Chief Advisor Pharmacy, Allied Health and National Immunisation Program. Office of the Chief Clinical Officers, Ministry of Health, New Zealand
- Stephanie Tay, Senior Manager, Chief Pharmacist’s Office, Ministry of Health, Singapore

Self-care is an integral part of healthcare systems, contributing to healthcare cost savings, better allocation of resources and improved health outcomes in the population. Pharmacists are well placed in the community to support health-related decisions and facilitate informed self-care. FIP aims to support pharmacists in this role through advocacy and by developing professional resources in the area of self-care. This event will showcase a variety of FIP publications, including the launch of a new handbook.

Learning Objectives:
Understand the contribution of self-care to universal health coverage (UHC)
Explore the role of pharmacists in supporting informed self-care
Showcase FIP’s materials in the area of self-care

Moderator:
-Sarah Dineen-Griffin, FIP CPS ExCo member - Australia

Panelists:
-Lars-Åke Söderlund, Vice-President, FIP Sweden
-Daragh Connolly, President Community Pharmacy Section, FIP Ireland
-Christopher John, FIP Lead for Data and Intelligence, FIP UK
-Rúben Viegas, FIP Practice Development Projects Coordinator, FIP Spain

The CPS Champion for Change 2021, Dr Odhiambo David, will share his vision on how pharmacists can better serve patients with mental health issues:
- Describe what service pharmacies should offer patients and/or healthcare systems to help tackle the mental health burden;
- In what ways can pharmacists support self-care and mental health patients having a more autonomous life; and
- How can digital health tools (either low or high tech) help community pharmacists improve outcomes and better support patients with mental health problems

Malaria is responsible for approximately 400 thousand deaths annually, resulting in an enormous public health burden on many of the tropical and subtropical countries. Although projects are ongoing in WHO, pharmaceutical companies and foundations, basic university-based research is also essential against for treatment and drug resistance in malaria. Engagement of young pharmaceutical scientists in the field is necessary to overcome this situation.

In this event, young PI and early carrier scientists / PhD students related to this scientific subject will be invited as speaker. Dr Eizo Takashima, Ehime University, Japan was invited as a speaker for preliminary lecture, and provide opportunity for young scientists to discuss about the science of malaria.

Learning objectives:

• Describe the development of malaria vaccine candidates.
• Defineseroepidemiology of malaria
• Recognize how early carrier pharmaceutical scientists can be involved in research on drug and vaccine development of malaria.

Moderators:
- Takuya Kumamoto, SIG NM Chair, Prof Hiroshima University, Japan
- Rebecka Isaksson, NGPS SIG Chair, Postdoctoral Research Associate UCL Department of Chemistry, UK

Panelists:
- Dr Eizo Takashima,Associate Professor, Ehime University, Japan
- Dr Wei-Chiao Huang, Post-doc State University of New York at Buffalo, US
- Dr Takaya Sakura, Assistant Professor Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan
- Khalid Garba Mohammed, Lecturer, Bayero University, Kano, Nigeria

At this event on World Cancer Day, we will explore innovations in pharmacy practice in the community and hospital pharmacy settings, in terms of supporting cancer patients throughout their journey. A panel of experts will present and discuss examples of innovative professional services in cancer prevention and screening, access to cancer treatments, adherence and continuity across transitions of care, among others.

The goal is to raise awareness of the important role that pharmacists can play in all areas of practice in terms of cancer prevention and management, in collaboration with other healthcare professionals.

Learning Objectives

• Identify and discuss the roles that community and hospital pharmacists can play in cancer prevention and management.
• Present examples of best practices of cancer-related professional services by pharmacists from around the world.
• Discuss the importance of supporting patients in a multi- and inter-professional approach
• Explore issues on the transitions of care, adherence to treatments and prevention and screening in cancer care

Moderators:
• Josep M. Guiu Segura, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain
• Daragh Connolly, President, FIP Community Pharmacy Section, Ireland

Panelists:
• Marko Skelin M.Pharm PhD. Board member of the European Society of Oncology Pharmacy; Assistant Professor, Faculty of Medicine, University of Rijeka, Croatia
• Robert Duncombe, Chief Pharmacist, Director of Pharmacy, The Christie NHS Foundation Trust, Manchester, UK
• Jan de Belie, Professional Affairs Advisor, Pharmaceutical Group of the European Union, Belgium
• Kofi Boamah Mensah, Oncology Pharmacist at Komfo Anokye Teaching Hospital (KATH) and adjunct lecturer at the Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Science, Kwame Nkrumah University of Science and Technology (KNUST), Ghana

Establishing a correlation between in vitro tests and in vivo product performance has always been a challenge for the pharmaceutical industry.  Without a link between specifications and in vivo performance, drug product manufacturing processes are often performed under unnecessarily tight controls. Furthermore, implementing changes post-product market approval can be challenging in a complex global environment.  This webinar will describe traditional and novel approaches towards establishing in vitro in vivo correlations. The main focus will be on solid oral dosage forms, however other dosage forms will also be discussed.

Moderators:
-Andreas Abend, Senior Principal Scientist, MSD, USA
-Horst-Dieter Friedel, FIP Chair Special Interest Group Regulatory Sciences and Quality, Germany

Panelist:
-Patrick Marroum, Senior Director in Clinical Pharmacology and Pharmacometrics AbbVie, USA

Recent technological advancements have revolutionized clinical practice, and there is need for a pharmaceutical workforce that is well-equipped to embrace, innovate, and capitalize on the benefits of digital health. Findings from the 2021 FIP report on digital health in pharmacy education revealed the need to develop courses, training material and experiential learning opportunities to prepare a digitally literate pharmacy workforce.

The Academic Pharmacy Section, supported by the FIP Provision and Partnerships programme, and many FIP constituencies led a ONEFIP project to develop the first FIP-developed online Train the Trainer (TtT) course. At this event, we will reflect on the progress made to date, launch the TtT course, which targets academics as well as educators in any sector in pharmacy, and how this initiative builds on FIP competency frameworks and reports.

Event outcomes:
1. To describe FIP’s response following the release of digital health in pharmacy education report in 2021.
2. To provide an overview of the FIP Global Platform for Provision and Partnerships.
3. To launch the FIP Train the Trainer online course on FIPx and generate interest in the course

Moderators:
- Barry Bleidt, Prof. Nova Southeastern University College of Pharmacy, USA
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK

Panelists:
- Dr. Catherine Duggan, CEO FIP, the Netherlands
- Aukje Mantel-Teeuwisse, Director Utrecht University School of Pharmacy, the Netherlands
- Dr. Dalia Bajis FIP Lead for Provision and Partnerships FIP, Australia/Bahrain
- Nilhan Uzman, Lead for Education Policy and Implementation FIP, The Netherlands
- Jaime Acosta-Gómez, CPS Professional Secretary, Community pharmacist, Farmacia Acosta, Spain
- Prof. Lilian Azzopardi Head, AIM Advisory Committee member, Department of Pharmacy University of Malta, Malta
- Chu-Chen Cheng, Provision and Partnerships Remote Volunteer, Pharmacist FIP, Chaina Taiwan
- Genuine A. Desireh, Provision and Partnerships Remote Volunteer, Pharmacist FIP, Kenya

Medication errors and adverse events cause significant harm to patients’ health and well-being. At this event we will present an overview of the range of Medication Review (MR) services and their definition, highlighting the difference between them and particularly with Medicines Use Review (MUR) in light of recent international updates.

Learning Objectives
• Explore medication review services
• Define MR and MUR
• Present the FIP Toolkit on MR & MUR

Moderator:
Tim Chen, President of FIP Social and Administrative Pharmacy Section, President FIP Social and Administrative Pharmacy Section - Australia

Panelists:
-Filipa Alves da Costa, Assistant professor University of Lisbon, Portugal
-Kurt E. Hersberger, University of Basel, Switzerland
-Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre, Practice Development Projects Assistant (consultancy), Canada

The United Nations General Assembly proclaimed 24 January as International Day of Education, in celebration of the role of education for peace and development. And FIP AIM will be celebrating this special day with a webinar on mental health and wellbeing for academics.

Because the COVID-19 pandemic had led to considerable impact on our physical and mental wellbeing, mental health has become the ‘shadow pandemic’. At this webinar, cultivating mental health and resilience for academics will be highlighted and academic strategies for will be discussed to emphasize the benefits of improved mental health and wellbeing in achieving a better work-life integration.

The participants who join the webinar will;
1. Discover the importance of fostering academic resilience for mental health and wellbeing during unprecedented times and beyond,
2. Address the necessary reasons to raise mental health awareness among academics for students and workplace,
3. Identify institutional strategies in supporting mental health and wellbeing of academic staff and students,
4. Optimize mental health for academic performance in higher education.

Chairs:
-Pierre Moreau, Dean FIP, Kuwait University, Kuwait
-Toyin Tofade, Dean Howard University College of Pharmacy, USA
-Mohamad Rahal, Dean Lebanese International University, Lebanon

Panelists;
-Neil MacKinnon, Provost and Executive Vice President for Academic Affairs Augusta University, USA
-Betty Exintaris, Senior Lecturer, Monash University, Australia
-Fatos Ilkay Alp Yıldırım, Associate professor Istanbul University, School of Pharmacy, Turkey

Facilitators:
-Nilhan Uzman, FIP Lead for education policy and implementation FIP, The Netherlands
-Ozge Ozer, FIP Educational Partnership Coordinator, Turkey

Pharmacy teams are increasingly providing services that support people to self-care with their sexual health. This webinar will focus particularly on advice, screening and testing, as well as appropriate management of choices of medicines and products to support sexual health. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can provide support to people to self-care with their sexual health.

Learning objectives:
1. Increase awareness of sexual health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support people with their sexual health;
3. Discuss appropriate management in the choice of medicines and products for the self-care of sexual health.
4. Describe the role that pharmacist and their team can play in screening, testing, advising and educating people sexual health and how they can self-care.

Moderator:
- Leonila Ocampo, Member of the FIP Community Pharmacy Section; President, Asia Pacific Institute for Medication Management, Philippines

Panelists:
- Irene Serrano, Community Pharmacist, Spain
- Wael Ali, Egyptian Organisation of Pharmacy, Egypt
- Luna El Bizri, Founder and Manager, Lunapharm Pharmacy, Lebanon

The year 2020 saw the COVID-19 outbreak become a global pandemic which, even by 700 days at the end of 2021, has highlighted how much the world has had to change and we have had to adapt our lives, ways of working, ways of living.

Despite the impact of the pandemic on 2020 business plans and working environments, FIP persevered to deliver and launch the FIP Development Goals for our members and the profession worldwide, understanding the need to provide directions and goals in the coming years as we live with and (hopefully) move out of the pandemic.

In 2021, we ran a full programme to identify the priority goals for the decade ahead across our regions and members. In this event we recap the key outcomes and priorities across the world region which we captured in a new report.

Join us for launch the FIP Development Goals Report 2021 “Setting goals for the decade ahead” which provides a global status update on the goals one year on since their launch and serves as an anchor point that will facilitate the next decade’s roadmap aligned with the UN Agenda 2030.

We will also be launching a new ‘microsite’, a digital platform that serves as a web-based resource for the Development Goals. The microsite collates FIP’s work, publications, events and other outputs mapped to the goals by theme, alongside tools and resources for our members.

Join us in one of FIP’s first events of 2022, where we stand by our commitment now and in the future to support our members to transform pharmacy with clear action, in solidarity with all!

This event discusses how targeted switching of prescription only medicines to non-prescription medicines (Over The Counter medicines) can contribute to self-care of a nation’s population. Availability of diagnostics in the pharmacy and beyond can also make an impact on self-care.

Aim: To discuss which medicines are appropriate to switch from prescription-only to non-prescription (Over The Counter Medicines) and describe how diagnostics can support self-care.

Learning objectives:
1. Describe current approaches to switching medicines from prescription to non-prescription and how this supports self-care ;
2. Discuss which medicines should be available over the counter in the pharmacy;
3. Explain how diagnostics can support self-care.

Moderator:
- Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Panelists:
- Natalie Gauld, Innovator in improving access to medicines Northern Regional Alliance, University of Auckland, New Zealand
- Andi Shirtcliffe, Clinical Chief Advisor for Pharmacy and Allied Health Ministry of Health New Zealand, New Zealand
- Anthony Serracino Inglott, Professor at the Department of Pharmacy Faculty of Medicine and Surgery, University of Malta, Malta

Summary

Pharmacy teams are increasingly supporting children and their carers with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support children’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim: To identify how the community pharmacy team can support self-care of common health problems for children and their carers.

Learning objectives: 

1. Increase awareness of children’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support carers and children with common health issues;
3. Discuss appropriate management in the choice of medicines and products.
4. Describe the role that pharmacist and their team can play in advising and educating carers and children so they can self-care.

Moderator:

• Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University, Australia

Panellist:

• Hadi Dassouki, Community Pharmacist, Lebanon
• Jack Collins, Postdoctoral Research Associate, The University of Sydney School of Pharmacy, Australia
• Joanne Crook, Consultant Pharmacist Paediatrics, Kings College Hospital, UK

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

The Global Advanced development framework (GADF) was developed to support the professional development and recognition of the pharmacy workforce everywhere and the Global Competency Framework (GbCF) was developed by the FIP as a focused support structure for early career pharmacists.  This digital event seeks to create more awareness for the GADF and GbCF and to enable early career pharmacists and pharmaceutical scientists have a better understanding of their structure.

Competency framework- A complete collection of competencies that are thought to be essential to performance.

Competencies – Knowledge, skills, behaviors and attitudes that individuals accumulate, develops, and acquires through the education, training and work experience.

Learning objectives:

• Describe the purpose and applications of both the Global Advanced Development Framework (GADF) and the Global competency framework (GbCF);
• Summarize the domains and illustrative competencies from the GbCF for pharmaceutical services (scientific knowledge and management knowledge)
• Identify an individual learning plan based on their learning needs obtained from the self-assessment of GbCF;
• Discuss approach to building a professional practice portfolio.

Moderator:

• Ayodeji Matuluko, Remote Volunteer, FIP Commission on AMR, PhD Candidate, Glasgow Caledonian University, Nigeria

In October-2021, FIP-UNITWIN Regional Workshops brought FIP’s member academic institutions, professional organisations, key pharmacy stakeholders and guests across all regions together to co-create a roadmap to advance pharmacy and pharmaceutical sciences in their region through educational partnerships. At the FIP-UNITWIN Global Summit on pharmaceutical education, participants will.

Learning objectives:
1. Learn about their regions’ roadmap on advancing pharmacy and pharmaceutical sciences education;
2. Explore FIP’s global call to action on pharmaceutical education to support it across their regions and countries;
3. Discover country cases and next steps of the FIP-UNITWIN Centres for Excellence programme

Chairs:

• Catherine Duggan, FIP CEO
• Ralph J. Altiere, FIPEd Chair

Speakers:

• Dominique Jordan, FIP President
• Luis Lorenco, FIP Professional Secretary
• Giovanni Pauletti, FIP Scientific Secretary
• Pierre Moreau, FIP AIM Chair

Panellists:

• Anne Anderson Vice Chair, UK National Commission for UNESCO
• Toyin Tofade, President-Elect of the FIP Academic Pharmacy Section (AcPS) & FIP AIM Advisory Committee Member
• Silvana Nair Leite, FIP AIM Advisory Committee member
• Lilian Azzopardi, AIM Advisory Committee member
• Aukje Mantel-Teeuwisse,FIP Digital Health in Pharmacy Education Report Chair, FIP Technology Forum Member, FIP APS Executive Committee Member
• Beom-Jin Lee, AIM Advisory Committee member
• Rajani Shakya, AIM Advisory Committee member
• Mohamad Rahal, AIM Advisory Committee member
• Rula Darwish, Academic Pharmacy Section Exco
• Paul J. Gallagher, AIM Advisory Committee member
• Mwila Chiluba, AIM Advisory Committee member
• Yahya Choonara, AIM Advisory Committee member
• Arinola Joda, Asst. Secretary/Editor in Chief, APF

Facilitators:

• Nilhan Uzman, FIP Lead for education policy and implementation
• Ozge Ozer, FIP Educational Partnership Coordinator
• Alison Ubong Etukakpan, FIP Educational Partnership Coordinator

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them. The 20^th episode of the Programme focuses on FIP Development Goal 14: Medicines Expertise. The details of the Goal are available here: https://www.fip.org/fip-development-goal-14

The expected outcomes of the event are:

1. Describe the FIP Development Goals and explain the components of DG 14 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 14 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 14
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:

• Dalia Bajis, FIP Lead for Provision and Partnership, Bahrain 

Panellist:

• Hala Fadda, Chair of FIP Pediatric Formulations Focus Group, Associate Professor, College of Pharmacy and Health Sciences Buter University, USA
• Sham Moodley, Pharmacist, FIP CPS Exco Member, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa

Summary
There is variability across the globe in the provision of universal healthcare. Self-care is the ability to maintain and improve individual’s health, prevent or limit diagnosed illnesses, and address self-treatable conditions. Self care is not no care and it is not necessarily practised in isolation. It may involve support and advice from others, such as expert pharmacy teams.  This event discusses how self-care can contribute to Universal Health Coverage from the perspectives of providers of healthcare services and public and patients. 

Aim: To discuss the perspectives of providers of healthcare services and the people accessing them about how self-care can contribute to universal health coverage.

Learning objectives: 

• Explain the extent to which self-care is embedded in healthcare systems;
• Discuss cultural approaches to enabling self-care as part of UHC, such as healthy lifestyles;
• List healthcare systems and patients/public’s needs for enabling self-care;
• Discuss the contribution of localised self-care delivery to UHC

Moderator:

• Sham Moodley, Community Pharmacist, Member of the FIP Community Pharmacy Section, South Africa

Panellist:

• K Srinath Reddy, President, Public Health Foundation of India, India
  
• Jacqueline Bowman-Busato, Co-Founder, Belgian Private Foundation Pate Adiposité Adipositas Pacte, Belgium
• Dave Burrows, CEO and CTO, Damibu, UK

Traditionally, the distribution of medicines to consumers has been organized through heavily regulated networks of physical pharmacies. The strict regulation of market structure has been in place to ensure the safety, accessibility and affordability of medicines, but it has also limited competition in the pharmacy sector. Nowadays, the regulation of pharmacies differs between countries, and this has created different market conditions for online pharmacies to operate.

In some countries the online sales of medicines have grown considerably during the recent years as consumers have become more accustomed to e-commerce. More lately the Covid-19 pandemic has dramatically shaped the e-commerce landscape. Due to the pandemic, the demand for online services of pharmacies has increased significantly in many countries. It is also likely that this has changed preferences for some consumers permanently and demand should therefore remain at a higher level in the future.

Increased cooperation between countries in developing regulation of online pharmacies is needed, according to the report, “Online pharmacy operations and distribution of medicines”, which will be published by the International Pharmaceutical Federation (FIP) on December 8th, 2021.

Moderator:

• Lars-Åke Söderlund, FIP Vice President, Executive Advisor, Apoteket AB, Sweden, Sweden

Co-Moderator:

• Sarah Dineen-Griffin, Lecturer, Health Service Management, Charles Stuart University, Australia

Panellist:

• Catherine Duggan, FIP CEO, The Netherlands
• Manjiri Gharat, Principal, K. M. Kundnani Pharmacy Polytechnic, India
  
• Sari Westermarck, Community pharmacist, Finland
  
• Jacqueline Surugue, Immediate Past Vice President FIP, France
• Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE) 
• Jorge Schlottke, Pharmacist, Centro Oncológico Integral de la Provincia de San Luis, Argentina
• John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
• Prosper Hiag, President, African Pharmaceutical Forum, Cameroon
• Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Summary:

Gastrointestinal symptoms have an impact on the health and wellbeing of individuals that can be debilitating, however, the majority of people can be supported by the pharmacy team to self-care and effectively manage their symptoms.

Aim: 

To explore: lifestyle factors that can cause or worsen gastrointestinal complaints and the role of pharmacy team in supporting the majority of customers to self-care and effectively manage their symptoms.

Learning objectives: 

1. List common GI symptoms and their impact on people;
2. Identify and suggest approaches to addressing lifestyle factors causing GI symptoms.
3. Discuss the role of pharmacy team to support people with GI symptoms to self-care

Moderator:
- Manjiri Gharat, FIP Vice-President, India

Panellists:
- Ruth Rudling, Advanced Clinical Pharmacist for Specialty Medicines, Mid Yorkshire NHS Trust (MYHT), UK
- Anja St. Clair-Jones, Consultant Pharmacist Gastroenterology, University Hospitals Sussex, UK

At this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections, as well as in providing care and support to people living with HIV, namely through medication management. Other roles for pharmacists include HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.

The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.

Learning objectives:
1. Describe the burden and characteristics of HIV globally.
2. Understand the possibilities of involvement of pharmacists in the clinical care of people living with HIV.
3. Describe the role of pharmacists in PrEP-related services.

Moderator:
- Victoria Garcia Cardenas, FIP Pharmacy Practice Research SIG, Chair Senior Lecturer University of Technology Sydney, Australia / Spain

Panelists:
- Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Nelli Barrière, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland
- Pilar Taberner Bonastre, Hospital pharmacist, Hospital Universitario Arnau de Vilanova, Lleida Spain
- Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, United States of America
- Tessa Oraro-Lawrence, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland

Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.

Este webinar tiene los objetivos:

• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos.
• Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS.
• Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina.
• Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.

Moderadora:
-Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica FIP

Panelistas:
-Alfredo García Arieta, Jefe del Servicio de Farmacocinética y Medicamentos Genéricos AEMPS
-Andrés Figueroa Campos, Gerente SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes
ANAMED ISPch–Agencia Nacional de Vigilancia Sanitaria de Chile
-Jorge Iliou, Dirección NVVS de Paraguay
-Alexis Aceituno,Jefe SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes ANAMED ISPch–ANVSChile
-Miguel Angel Cabrera Prof. Asociado Central University of Las Villas

The global session entitled  ‘Accelerating AMR Action Through Antimicrobial Stewardship:  Are pharmacists the protagonists in the fight against antibiotic resistance?’ takes a debate format with 2 teams of three, protagonists and antagonists, speaking to a case study or personal experience to highlight good (protagonist) or bad (antagonist) practice that reflects the reality of the challenges faced by pharmacy in tackling AMR, with a particular focus on low to middle income countries

Moderators:
- Sabiha Essack
- Manjiri Gharat

Welcome and Objectives:
- Introducing FIP AMR Commission and goals of GRIP partnership; overview of 2020 -2021 roadmap progress
Panel Discussion:
- ‘Are pharmacists the protagonists in the fight against antibiotic resistance?’
Using case studies to highlight best practice, as well as bad practice, to reflect the reality of the challenges faced by pharmacy in tackling AMR, with a particular focus in low to middle income countries

Regional Highlights:
- Highlights of the regional ideas that delivered most change/progress towards the AMR roadmap developed in our FIP Virtual 2020 events

Next steps and close:
- Next steps and role of the AMR Commission; renewed commitment to AMR going forward

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the South East Asian Region over the past 12 months.

Moderators:
- Manjiri Gharat
- Wirat Tongord

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Eastern Mediterranean Region over the past 12 months.

Moderators:
- Dalal Hammoudi,
- Khalid Eljaaly
- Nada Ahmed

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the European Region over the past 12 months.

Moderators:
- Phillip Howard,
- Elsa Lopez Pintor
- Cátia Caneiras

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Western Pacific region over the past 12 months.

Moderators:
- John Bell
- Leonila Ocampo,
- Fiona Doukas

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the African Region over the past 12 months.

Moderators:
- Sabiha Essack
- Mirfin Mpundu

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 19^th episode of the Programme focuses on FIP Development Goal 17: Competency Development. The details of the Goal are available here: https://www.fip.org/fip-development-goal-17  

FIP Development Goal 17 calls for workforce and education strategies linked to the use of evidence-based developmental frameworks to support the translation of pharmaceutical practice, science and workforce & education  across all settings and according to local/national needs.

The goal calls to support professional career development by using tools, such as competency frameworks, describing competencies and behaviours across all settings.

The expected outcomes of the event are:

• Describe the FIP Development Goals and explain the components of DG 17 (and its three elements: workforce & education, science and practice).
• Showcase the FIP tools, evidence, and resources to support DG 17 implementation across the three elements.
• Identify priorities across practice, science, and workforce & education within DG 17
• Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:
-Wirat Tongrod,  FIP AMR committee, Vice President, The Pharmaceutical Association of Thailand under Royal Patronage, Thailand

Co-moderator:
-Ayodeji Matuluko, Remote Volunteer, FIP Commission on AMR, PhD Candidate, Glasgow Caledonian University, Nigeria

Panelists:
-Cátia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal
-Chin-Yen Yeo, FIP AMR Commission - Member, Antimicrobial Stewardship Pharmacist Blacktown & Mt Druitt Hospitals, Western Sydney Local Health District, Australia
-Mirfin Mpundu, Director, ReAct Africa International Centre for Antimicrobial Resistance, Zambia
-Dalal Hammoudi, FIP WiSE steering committee and FIP AMR commission member, Associate Dean for Assessment, Lebanese International University – School of Pharmacy, Lebanon

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Americas Region over the past 12 months.

Moderators:
- Eduardo Savio
- Doug Burgoyne

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

Sore throat is a common self-limiting condition which often leads to patients presenting in the pharmacy for advice, treatment options and reassurance. Sore throat is predominantly a viral condition for which symptomatic management offers the most appropriate course of action. Effective diagnosis, communication and managing expectations can prevent unnecessary onward referral or inappropriate antibiotic use.

Aim:
To help pharmacists enhance their role as the primary healthcare professional in the appropriate management of sore throat through improved communication and appropriate management that supports self-care.

Learning objectives:
1. List the presenting symptoms of sore throat
2. Explain the diagnosis of sore throat
3. Describe an evidence-based approach to treatment options

Moderator:
-Sabiha Essack, Professor: Pharmaceutical Sciences
South African Research Chair in Antibiotic Resistance & One Health, University of KwaZulu-Natal, South Africa

Panellists:
-Douglas Bourgoyne, Principal Cooperative Benefits Group, LLC, USA
-John Bell, Community pharmacist and Self-care Advisor
Pharmaceutical Society of Australia, Australia
-Wirat Tongrod, Member of AMR Commission, Lecturer – Faculty of Pharmaceutical Sciences, Huachiew Chalermprakiat University- Thailand

Antimicrobial resistance (AMR) is a major public health threat, which currently kills around 700,000 people each year worldwide. The fight against AMR has been a priority for FIP for many years as it causes a profound impact on global, regional and national health care and economies. The goal of this webinar is to supplement the other FIP webinars being held in November 2021 discussing AMR regionally around the globe. This webinar specifically targets pharmacists involved in hospital and health-system practice settings and will discuss innovative ways to involve pharmacists in infectious disease through AMR and sepsis management.

Learning objectives:
1. Introduce the antimicrobial stewardship program in hospital pharmacy using clinical decision support system
2. Discuss the role and importance of the pharmacist in the management of sepsis
3. Evaluate the use of software and information technology to support antimicrobial stewardship in the critically ill

Moderator:
Krutika Mediwala Hornback, Clinical Pharmacy Specialist - Infectious Diseases/Antimicrobial Stewardship MUSC Health, USA

Panelists:
-Esteban Zavaleta, Director of Pharmacy, Hospital Clinica Biblica, Costa Rica
-Shu-Wen “Wendy” Lin, Director of Pharmacy, National Taiwan University Cancer Center, Taiwan
-Asad “Sid” Patanwala, Professor and Chair of Clinical Pharmacy University of Sydney | Royal Prince Alfred Hospital, Australia

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

About the programme:

FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

Despite all good intentions, all humans carry unconscious biases. How do these impact our ability to provide culturally appropriate care to our patients? This interactive session is meant to target all pharmacists and educators in practice to promote understanding on the influence of unconscious bias on health disparities, like COVID-19. Specifically, experts will share the neuroscience of how implicit bias, strategies to disrupt bias, and address how bias can influence our patient care interactions.

At the end of this session, participants will be able to:
1. Define implicit bias and its impact on health disparities.
2. Discuss the impact of unconscious bias and how it affects our relationships with patients, students, and colleagues.
3. Identify and reflect on own biases.
4. List strategies to mitigate unconscious bias in pharmacy practice to improve patient-centred care.

Moderator:
- Mohamed Amin, Associate Professor, Beirut Arab University, Lebanon

Facilitator:
- Dalia Bajis, FIP lead for Provision and Partnerships, FIP, Bahrain

Panellist: 
- Sally Arif, Associate Professor of Pharmacy Practice/ Clinical Pharmacist, Midwestern University College of Pharmacy/ Rush University Medical Center, USA

El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP. 

1) Reconocer la contribución del farmacéutico a las estrategias de vacunación y su relación con los objetivos de desarrollo de la FIP y las prioridades de salud globales.

2) Describir los beneficios, el impacto y las barreras de la inmunización en general y la vacunación en particular, así como experiencias de éxito del farmacéutico como inmunizador a nivel global.

3) Identificar experiencias de éxito del farmacéutico en América Latina en vacunas y su participación en las distintas etapas de la cadena de inmunización-

4) Reconocer las áreas de servicio de la inmunización en el quehacer farmacéutico y las herramientas disponibles para el desarrollo de servicios farmacéuticos de inmunización desde los diferentes ejes de su competencia.

The document "Pharmaceutical services in immunisation: Contributions, experiences and implementation in the Americas region", authored by the Drug Information Centre of the Pharmaceutical Research Institute of the Faculty of Pharmacy of the University of Costa Rica for the Pharmaceutical Forum of the Americas, provides an overview of the involvement of the pharmacy profession in immunisation in Latin America. This introductory webinar will provide an overview of the document’s content and how it relates to the FIP Development Goals. This document is intended to be a tool for the implementation of pharmaceutical services in immunisation in the region, which also complements other reports issued by FIP. The document is available in Spanish, English and Portuguese.

1) Recognise the pharmacist's contribution to immunisation strategies and their relationship to FIP Development Goals and global health priorities.

2) Describe the benefits, impact and barriers of immunisation in general and vaccination in particular, as well as successful experiences of pharmacists as immunisers globally.

3) Identify successful experiences of pharmacists in Latin America in vaccines and their participation in the different stages of the immunisation chain.

4) Recognise the service areas of immunisation in pharmacy and the tools available for the development of pharmaceutical immunisation services from the different areas of their competence.

Covid-19 complications include a wide spectrum of clinical manifestations. COVID-19 -associated invasive mould infections have been identified as a serious global health problem. These invasive infections present differently and vary in their risk factors. Pharmacists can play a vital role in raising awareness, prevention, and treatment of these emerging pathogens. In addition, pharmacists’ role is vital to providing care to patients suffering from Long Covid. Long Covid conditions are a wide range of new, returning, or ongoing health problems people can experience for four or more weeks after contracting SARS-CoV-2. These complications can occur in individuals with serious, mild, or no symptoms during the SARS-CoV-2 infection. However, the burden is not well understood and treatment approaches need further study.

This webinar will raise awareness of the pharmacist's role in supporting patients with COVID-19 associated mould infections and Long Covid.

Learning objectives:
1. Recognize manifestations and risk factors of Long Covid.
2. Provide actionable steps to care for people with post-covid conditions -as part of multi-disciplinary teams.
3. Describe common manifestations and risk factors of COVID-19-associated mould infections.
4. Identify prevention measures for COVID-19 associated mold infections.
5. Recognize treatments for COVID-19-associated mould infections.

Moderator:
- John Hertig, VP Americas (PAHO), Assoc. Prof. and Vice-Chair of Pharmacy Practice, Butler University, USA

Panelists:
-Dallas James Smith, Epidemic Intelligence Service Officer/Pharmacist Mycotic Diseases Branch, Centers for Disease Control & Prevention, United States
-Stacey L. Konkle, Epidemic Intelligence Service Officer/Epidemiologist Field Officer, Epidemiology Workforce Branch, Centers for Disease Control & Prevention, United States

This webinar aims to identify the challenges and opportunities for pharmacists in addressing diabetes, highlight the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes-related services, understand the role that pharmacists can play in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD). The event will culminate with the launch of the ONE FIP Practice Transformation Programme on Diabetes.

This event will also close the series of five webinars organised by FIP to explore the role of pharmacists in the prevention and management of diabetes and its complications; the advancement in therapeutic options; the competencies and workforce development opportunities; and the policy barriers and facilitators in providing diabetes-related services.

At the end of this webinar, participants will:
• Identify the challenges and opportunities for pharmacists in addressing diabetes
• Recognize the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes services
• Understand how the role of pharmacists can be elevated in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD) 14 November

Moderator:
-Paul Sinclair, FIP Chair Board of Pharmaceutical Practice, Community Pharmacist, Australia

Panelists:
-Tolulope Osigbesan, Advocacy and Partnerships Officer, NCDs Alliance, Switzerland
-Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine
-Jean-Baptiste Nikiema, Regional advisor, EDM, WHO Regional Office for Africa, Republic of Congo
-Gonçalo  Sousa Pinto, FIP Lead for Practice Development and Transformation, Spain
-Lauren Blum, Global engagement fellow, UNC Eshelman School of Pharmacy, USA
-Rúben Viegas,FIP Practice Development Projects Coordinator, Spain
-Aniekan Ekpenyong, Practice Transformation Projects Coordinator FIP, Nigeria
-Michael Donohoe, Global Patient Advocate, A1C Wellness {Diabetes...], USA

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 18th episode of the Programme focuses on FIP Development Goal 3: Quality Assurance.

Learning objectives:
1. Describe the FIP Development Goals and explain the components of DG 3 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 3 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 3
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project
Moderator:
-Banan Mukhalalati, Global Lead for Development Goal 3 “Quality Assurance” Assistant Professor, Qatar University, Qatar
Panelists:
-Mike Rouse, Former FIP Education Development Team Lead for Quality Assurance, Director, International Services, Accreditation Council for Pharmacy Education, USA
-Abby A. Kahaleh, DG3 Lead, PhD, MS, BPharm, MPH, FAACP Tenured & Board of Trustees Faculty Roosevelt University College of Science, Pharmacy, & Health, USA
-Bronwyn Clark, DG3 Lead Chief, Exec. Officer
Australian Pharmacy Council, Australia
-Abeer Alghananeem, DG3 global lead, Prof & Director of Research Sullivan University College of Pharmacy & Health Sciences, USA & Jordan
-Aline Hajj, Assoc. Prof, PharmD, PhD Researcher and Lecturer, Saint Joseph University, Lebanon
-Marwan Akel, Projects Manager Workforce FIP, Lebanon

Cytotoxic drugs compounding is one of the most risky activity among all pharmaceutical operations in a Pharmacy. This has led pharmacists to multiply check points at each critical step and in-process controls to keep that risk at the lowest, as reported in numerous publications. What can technology bring in terms of safety, speed, convenience, and reliability in such complex environments ? Three exemples will be discussed in this webinar: CSTDs, IV workflow management system with IA technology and video recording, and robotic compounding.
And if you are addicted to serious games, come and see how you can increase your competencies while training in immersive virtual reality in a real cytotoxic drugs compounding environment

Moderators:
-Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, Immediate past FIP Vice President and Liaison Officer for the African Region
Hospital Pharmacist, Hospital Practitioner, Centre Hospitalier Georges Renon, Niort, France
-Josep M. Guiu Segura, HPS ExCo, Head of pharmaceutical planning and pharmacotherapy coordination Consortium of Health and Social Care of Catalonia, Spain

Panelists:
-Benoit Le Franc, Pharmacist Pharmacien hospitalier gérant PUI GHLRRA-co-fondateur chez EUREKAM SAS-inventeur Drugcam, France
-Agnés Bobay-Madic, Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
-Mirjam Crul, Pharmacist, Board Member, European Cancer Organisation, Special Network on the impact of COVID-19 on Cancer Co-Chair and workforce Network Co-Chair, The Netherlands
-Shao-Chin Chiang, Pharmacist Sun Yat-Sen Cancer Centre, Taiwan

This webinar aims to highlight strategies for developing a diabetes competent workforce, explore success stories of countries that have developed competency framework for diabetes-related roles and to identify relevant competencies essential for the delivery of diabetes services by pharmacists.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:
-Understand the strategies for developing a diabetes competent workforce
-Learn from successful experiences on how to develop competency framework for diabetes related roles
-Identify relevant competencies facilitating the delivery of diabetes-related services

Moderator:
-Ralph Altiere, Chair of FIP Education (FIPEd) University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA

Panelists:
- Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist. University of Huddersfield. Sheffield Teaching Hospitals NHSFT, United Kingdom
- Andreia Bruno-Tomé,  Global Lead for DG 5 - Competency Development, Senior Expert Strategist, McCann Health, Portugal
- Diana Isaacs, Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, USA

In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
- Dr. Prosper Hiag – President of the African Pharmaceutical Forum (APF)
- Mrs. Jacqueline Surugue – Chair of the FIP Technology Forum and Hospital Practicioner and Pharmacist, France
-
The speakers at the event are:
- Dr. Daniella Munene – CEO of the Pharmaceutical Society of Kenya
- Dr. Samuel Adekola – Community Pharmacist at His Grace KSP Pharmacy Group and Immediate Past National Chairman of Association of Community Pharmacists of Nigeria
- Dr. Redouane Soualmi - Vice president of international relations of Algerian Pharmaceutical Federation FAP
- Dr. Mariet Eksteen - Professional Development and Support at the Pharmaceutical Society of South Africa

This webinar aims to describe the advancement in diabetes therapeutics for managing diabetes, highlight the role of technology in improving health outcome of individuals living with diabetes and identify the different services employed in the optimization of diabetes treatment.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes

At the end of this webinar, participants will:

• Describe the advancement in diabetes therapeutics for managing diabetes
• Explain the role of technology in improving health outcome of individuals living with diabetes
• Identify the different services employed in the optimization of diabetes treatment

Moderator:
Ross McKinnon, Chair of BPS, Chair of Board of Pharmaceutical Sciences, FIP Australia

Panelists:
-Antria Pavlidou, YPG PharmSci Promotion, PhD Candidate, Clinical Pharmacist  Pharmaceutical Services, Ministry of Health, Cyprus / PhD Candidate UCL, Cyprus
-Kalyan Venkata, Assistant Professor, Medicinal Chemistry, Pharmaceutical and Administrative Sciences,
University of Health Sciences and Pharmacy in St. Louis, USA
-Anna Busquets Casso, Community pharmacist, SEFAC, Spain

In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Mr. John Jackson - President of the Western Pacific Pharmaceutical Forum, Australia
• Professor Parisa Aslani - Professor in Medicines Use Optimisation at The University of Sydney and FIP Vice President

Panelists:
- Dr. Amrahi Buang - President of the Malaysian Pharmacists Society (MPS)
- Dr. Stephanie Tay - Senior Manager at the Ministry of Health, Singapore
- Mrs. Leonila M. Ocampo - Former President and Member of the Council of Advisers, Philippine Pharmacists’ Association
- Mr. Chris Campbell - General Manager, Policy & Program Delivery and Queensland State Manager at the Pharmaceutical Society of Australia

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The expected outcomes of the event are:
1. Describe the FIP Development Goals and explain the components of DG 5 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 5 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 5
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderators:
-Elizabeth McCourt, Health Professional Research Coordinator Queensland Health, Australia
-Marwan Akel, FIP projects manager- workforce, FIP Lebanon

Panelists:
-Arijana Meštrović, FIP ACPS Vice President, FIP WDH Global Lead for Competency Development Director, Professional services Pharma Expert, Croatia
-Sylvain Grenier, MEPS president Director Plasma Protein and related products Canadian Blood Services,
Canada
-Andreia Bruno-Tome, Global Lead for DG 5 - Competency Development ,Senior Expert Strategist
McCann Health, Portugal
-Naoko Arakawa, Global Lead for Competency Development, Assistant Professor in International Pharmacy, University of Nottingham, UK

In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Chinta Abaywardana – Editor, Pharmaceutical Society of Sri Lanka
• Sherly Meilianti – Data and Intelligence Specialist, FIP

The speakers at the event are:
• Rao Vadlamudi – Professional Secretary of SEARPhorum
• Bhojraj Suresh - Pro Chancellor, JSS Academy of Higher Education and Research, India
• Keri Lestari - Lecturer and Pharmacist, Universitas Padjadjaran, Indonesia
• Vindya Pathiraja - General Secretary of the Pharmaceutical Society of Sri Lanka
• Sanjeev Sharma Kattel - Pharmacy Officer/Acting Chief, Department Of Drug Administration, Kathmandu, Nepal

3D printing offers the potential to revolutionise the production of pharmaceuticals targeted to the gastrointestinal tract by offering a flexible drug product manufacturing platform that can adapt readily to changing market and patient needs.
When will a pharmacist be able to use each patient’s individual information — such as age, race, gender or constitution — to produce their optimal medication dose, rather than relying on a standard set of doses? Could there be a time when a pharmacist will be able to print drugs in a complex construct of layers? When will patients be able to print their medicines at home?

Describe the generalities related to 3D printing of medicines.
Understand the opportunities, issues and regulation related to 3D printing of medicines.
Learn how different technological tools allow personalised 3D printed medicines.
Outline a practical experience in 3D printing in pharmacies

Moderator:
- Jaime Acosta, Community Pharmacy Section’s Executive Committee Member, FIP CPS, Spain

Panellists:
- Alvaro Goyanes Goyanes, Co-founder and Director of Development, FabRx Ltd, United Kingdom
- Patrick van Oirschot, Director | Consultant, GPP Support, Netherlands
- Jan Saevels, Scientific Director, Association of Pharmacists Belgium (APB), Belgium

On 25 October 2021, it will be the third anniversary of the World Health Organization’s Astana Declaration on Primary Health Care (PHC), for which FIP pledged its commitment to accelerate progress in strengthening PHC. In 2020, the WHO published its Operational Framework for PHC to translate the vision of the Astana Declaration into actions. To mark this date and showcase how pharmacists can utilise and contribute to the WHO operational framework, FIP is organizing the digital FIP Global Summit on Primary Health Care. The summit will host a high-level discussion with the WHO to explore the strategic levers needed for pharmacists to strengthen primary health care.

At the end of this session, participants will:

1. Learn about WHO’s operational framework on primary health care to translate vision into actions
2. Explore initiatives from FIP member organizations on primary health care
3. Engage in a high-level discussion on strategic priorities needed for pharmacists to strengthen primary health care

Co-Moderator:
- Dominique Jordan, President FIP - Switzerland

Co-Moderator:
- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP - Australia

Facilitator:
- Nilhan Uzman, FIP Lead for Education Policy and Implementation, FIP - The Netherlands
- Aysu Selcuk, FIP Educational Partnership Coordinator, FIP - Turkey

Panellists:
- Catherine Duggan, CEO, FIP - The Netherlands
- Nisa Masyitah, Master's Student, The Graduate Institute of International and Development Studies (IHEID) - Switzerland
- Shannon Barkley, Technical Officer, Primary health care World Health Organization/HQ - Switzerland
- Anne L. Burns, Vice President of Professional Affairs, American Pharmacists Association - United States
- Eric Muringu, Projects Lead, Pharmaceutical Society of Kenya - Kenya
- Yong Pei Chean, President, Pharmaceutical Society of Singapore - Singapore
- Anoushka Schut, Heading the Policy & Development Cluster, Member of the Management Team of pharmacist association - The Netherlands
- Roy Himawan, Head of Program and Information Section Secretariat of the Directorate General of Pharmacy and Medical Devices at Ministry of Health, Indonesian Pharmacists Association / Ministry of Health, Indonesia
- Zeid Kilani, President, JAP, Jordan

This webinar aims to describe the different services provided by pharmacists to manage diabetes, explore the role of pharmacists in preventing the complications of diabetes, and highlight the importance of collaboration with other health professionals in achieving treatment goals

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:

• Describe the different services provided by pharmacists to manage diabetes
• Identify the role of pharmacists in preventing the complications of diabetes
• Understand the importance of collaboration with other diabetes health professionals in achieving treatment goals

Modarator:
Tim Chen, President FIP Social and Administrative Pharmacy Section,
Australia

Panelists:
-Sanah Hasan, President of FIP Social and Administrative Pharmacy Section, Associate Professor Ajman University, College of Pharmacy and Health Sciences, United Arab Emirates
-Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland
-Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy,
Puerto Rico
- Mara Pereira Guerreiro, Invited Professor, Nursing School of Lisbon & Instituto Universitário Egas Moniz Nursing School of Lisbon & Instituto Universitário Egas Moniz, Portugal

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event will gather different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.

Learning objectives:
1. Understand the role of the various civil society organisations in contributing to increased vaccination coverage.
2. Explore drivers and barriers to diversifying vaccination pathways and providers, allowing for better access to vaccination services.
3. Discuss possible actions and synergies by the different stakeholders in addressing vaccine hesitancy and complacency.

Moderator:
- Catherine Duggan, CEO, FIP

Panellists:
- Jane Barratt , Secretary General, International Federation on Ageing
- Mariano Votta, Director, Active Citizenship Network
- Iryna Vlasenko, Vice president, International Diabetes Federation
- Siân Williams, CEO, International Primary Care Respiratory Group
- Gary Finnegan, Editor, Vaccines Today

Ten years after the first FIP Pharmacy Technicians’ Symposium, we invite you to attend this year’s virtual event. The 2021 Pharmacy Technicians’ Symposium will take place on 19 and 20 October in celebration of World Pharmacy Technician Day (October 19). Take a look at the full programme here: https://bit.ly/3a8fGfa

Symposium Programme

13:00 - 14:30 CEST

Trends in digital health technologies require the entire pharmacy workforce to prepare for and adapt to constant change.
This session will explore how pharmacy technicians can best engage in advances in digital health.

Learning Objectives:
● Recognize emerging trends in digital health technologies
● Identify digital tools that aid in the delivery of patient care
● Describe the role of pharmacy technicians in digital health

Chairs: Christina Durinck (Denmark) & Ryan Burke (US)

Speakers:
● Jacqueline Surugue (France)
● Vijay Sarma (Canada)
● Peter Karegwa Mwangi (Kenya)
● Giada Crivelli & Karen Chin (Australia)

14:30 - 14:35 CEST Break

14:35 - 15:50 CEST
Unique Pharmacy Technician Activities “Things you didn't know pharmacy technicians do”

Pharmacy technicians across the globe play a key role in all aspects of pharmacy practice. Some roles are well known, while others are less common but equally important in terms of patient care.

This presentation will focus on unique roles for pharmacy technicians, including academia, radiopharmaceuticals, transplant, medicines administration, and more.

Learning Objectives:
● Identify unique roles for pharmacy technicians
● Describe the education, training, and experience required for pharmacy technicians to engage in certain areas of pharmacy practice
● Recognize the key tasks and responsibilities of pharmacy technicians working in transplant, medication administration, smoking cessation, and pharmaceutical manufacturing and distribution.

Chairs: Tamara Koehler (Netherlands) & Cathy Schuster (Canada)

Speakers:
● Amareen Kamboh & Claire Williams (UK)
● Rachelle Shelkey (Canada)
● Karen Hemmingsen (Denmark)
● Marianne Timm (Denmark)

15:50 - 16:00 CEST Symposium Closing Remarks

“This webinar is part of the FIP virtual Global Pharmacy Technicians’ Symposium 2021 programme! The symposium will continue on 19 October at 15:00 CEST and on 20 October at 13:00 CEST. Take a look at the full programme and register for each day here: https://bit.ly/3a8fGfa”

Moderator:
-Marwan Akel, FIP projects manager- workforce FIP, Lebanon

Panelists:
-Silvana Nair Leite, DG 8 Leads, Hub, Professor Universidade Federal de Santa Catarina, Brazil
-Victoria Garcia Cardenas, Chair, Pharmacy Practice Research SIG, Senior Lecturer, Pharmacy University of Technology Sydney, Australia
-Mujahidhussein G Valji, Vice President, Hospital Pharmacy Section, Africa Region Chief Pharmacist Aga Khan Health Services, Tanzania
-Susan James, Lead for the FIPEd Pharmacy Technicians and Support Workforce Strategic Platform and Chair, Pharmacy Technician Advisory Committee Director, Quality Ontario College of Pharmacists, Canada
-Daragh Connolly, Interim President, Community Pharmacy Section, FIP ExOfficio President Irish Pharmacy Union, Ireland
-Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland
-Jill Martin Boone, Associate Director, HUB
DG8 lead, Director of Interprofessional Education James L. Winkle College of Pharmacy
University of Cincinnati, USA

Ten years after the first FIP Pharmacy Technicians’ Symposium, we invite you to attend this year’s virtual event. The 2021 Pharmacy Technicians’ Symposium will take place on 19 and 20 October in celebration of World Pharmacy Technician Day (October 19). Take a look at the full programme here: https://bit.ly/3a8fGfa

15:00 – 15:30 CEST Opening session - FIP HQ Representatives / Leadership

15:30 - 17:00 CEST Leadership and Pharmacy Technician Workforce Development

Description: A strong pharmacy support workforce is a key component of FIP’s workforce development initiatives. This session will explore leadership roles and opportunities for pharmacy technicians and highlight strategies for further developing the pharmacy technician workforce.

Learning Objectives:
● Identify FIP Workforce Development Goals related to the pharmacy support workforce.
● Review leadership roles and opportunities for pharmacy technicians
● Describe pharmacy technician career ladders
● Discuss professional development strategies for pharmacy technicians

Chairs: Liz Fidler (UK) & Zachary Green (US)

Speakers:
● Kate Thorndike (UK)
● Vibhuti Arya (US)
● Jill Boone (US)
● Abigail Tan Ming Li (Singapore)

Pharmacy and pharmaceutical sciences encompass a very diverse field. The options are almost infinite as science and practice evolves. It is therefore of great advantage for young pharmacists if they can discover their path early on in their careers.
In this webinar, information about different career paths and opportunities will be shared with participants with the aim of helping them navigate the career paths and opportunities in diverse settings and specialist areas.

By the end of the webinar, participants will be able.
1. To understand the possible career paths and opportunities for young pharmacists in industrial pharmacy.
2. To understand the possible career paths and opportunities for young pharmacists in Academia.
3. To understand the possible career paths and opportunities for young pharmacist in regulatory pharmacy.

Moderator:
-Onyeka Obidiegwu, Member relations Coordinator, FIP YPG Subcommittee 2021, Pharmacist Nnamdi Azikiwe University, Awka Nigeria

Panelists:
-Clement Haeck, FIP YPG Twitter Manager, FIP YPG Subcommittee 2021 Researcher The Population Council, USA
-Yoonjung Choi, Member/Previous Career Development Toolkit Working Group, Research Scientist
Korea Institute for Pharmaceutical Policy Affairs Republic of Korea
-Anisha Sandhu, FIP YPG Workforce Development Hub Liaison, Assistant Lecturer Monash University Malaysia, Malaysia
-Angeliki Kopsini, Medical Science Liaison Cardiovascular Bayer Hellas, Pharmaceutical Division, Greece

Hygiene practices including hand and surface disinfection form part of our first line of defence by helping to reduce the spread of the infections such as COVID-19. These interventions also have an impact on many common infections such as cold and seasonal flu. The pharmacy team are the most accessible healthcare provider and are a convenient source of advice for patients and public in the maintenance of appropriate hand and surface hygiene practices.

Aim:
To explain the benefits of hand and surface disinfection in stopping the transmission of a range of common infections that are transmitted in the home and everyday life setting and profile the role the pharmacy team can play in providing patient and public education on disinfection in disease containment and management.

Learning objectives:
1. Explain the importance of hand and surface disinfection
2. List common infections/conditions where hand or surface transmission plays a role
3. Discuss the evidence-base for disinfection practice including use of appropriate disinfectants
4. Describe the role that pharmacist and their team can play in advising and education patients and public about disinfection.


Moderator:
-Cátia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal

Panelists:
-Sally Bloomfield, Honorary Professor London School of Hygiene and Tropical Medicine, UK
-Dalal Hammoudi, Assistant Professor Chairperson; Pharmaceutical Sciences Department School of Pharmacy; Lebanese International University, Lebanon
-Mirfin Mpundu, Director, ReAct Africa International Centre for Antimicrobial Resistance, Zambia

In the third of six regions we focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Ema Paulino – Immediate Past Professional Secretary at the International Pharmaceutical Federation (FIP) – Portugal
• Stephanie Kohl - Policy & Advocacy Officer at the European Association of Hospital Pharmacists (EAHP) – Belgium

The speakers at the event are:
- Koen Straetmans - President of the Belgian Pharmaceutical Association (APB)
- Piotr Merks – Adjunct professor at the Faculty of Medicine, Cardinal Stefan Wyszynski University in Warsaw,
- Vibhu Paudyal - Senior Lecturer in Clinical Pharmacy, University of Birmingham and Chair of the Research Committee at the European Society of Clinical Pharmacy (ESCP)
- Monika Derecque-Pois - Director General of the European Healthcare Distribution Association (GIRP)
- Mary Ann Sant Fournier - President of Malta Chamber of Pharmacists

Anticoagulant therapy requires appropriate monitoring and management to ensure safety and effectiveness of the treatment, avoid complications and to achieve optimal clinical outcomes. Pharmacists can play an important role in anticoagulation therapy management through their expert knowledge of medicines. This role also includes the provision of patient education, identification of drug interactions, monitoring for dose appropriateness and checking for adverse effects. This webinar will explore the various roles that pharmacists can play in providing anticoagulation management services.

At the end of this webinar, participants will:
1. Identify the different issues impacting anticoagulation management
2. Recognize the crucial role of pharmacists in enhancing the management of anticoagulation
3. Explain the role technology can play in supporting anticoagulation management
4. Describe the barriers and opportunities for pharmacists in leading anticoagulation management services

Moderator:
Carlos Lacava Fernández, Vice President of FIP, Uruguay

Panelists:
-Sahimi Mohamed, Clinical Pharmacist Hospital Serdang, Ministry of Health, Malaysia
-Nida Najmi, Founder of Online Anticoagulation
Management Services & Mahir-e-Adviyat, Pakistan
-Rose Anne, Coordinator, Anticoagulation Stewardship Program, University of Wisconsin Hospital and Health System (UW Health), Madison, Wisconsin, USA

To advocate for broader, harmonized implementation of biopharmaceutics classification system (BCS)-based biowaivers in Latin American countries, FIP is supporting regional leaders in raising awareness for this science-based regulatory pathway designed to accelerate market approval of safe and effective generic drug products. The first part of this webinar series specifically designed for the Latin American region centers on the fundamental scientific concepts underlying the BCS-based biowaiver regulatory pathway. Experts will address the different tools that can be applied to generate valid scientific evidence in support of BCS-based biowaiver applications.

In collaboration with Sindusfarma, Legis Consultoria, and Innovation and Biopharmaceutical Evaluation Center. 

This webinar has the objectives:

• To differentiate between in vivo bioequivalence and BCS-based biowaiver regulatory strategies for approval of generic drug products.
• To understand the scientific principles guiding the BCS-based biowaiver regulatory pathway.
• To delineate the contributions of solubility, permeability, and dissolution for BCS-based biowaiver applications.

Moderator:
- Talita Ferreira, Latin America Biowaiver Project Manager, International Pharmaceutical Federation (FIP) - Brazil

Panellists:
- Maria del Val (Marival) Bermejo Sanz, Professor, Miguel Hernández University - Spain
- Isabel González, Professor, Miguel Hernández University - Spain
- Gladys Granero, Professor, University of Córdoba - Argentina
- Pablo González, CEO, Innovation and Biopharmaceutical Evaluation Center, Chile
- Miguel Angel Cabrera-Pérez, Associate Professor, Central University of Las Villas, Cuba

Building on World Health Professions Alliance (WHPA), Positive Practice Environments Campaign, the “FIPWiSE toolkit for positive practice environments in education & science” is developed to identify and address inequalities in the workplace environments which affects women in pharmaceutical science and pharmacy education, with transferable learnings across the pharmaceutical workforce. The toolkit is designed to raise awareness and provide possible solutions for individuals, employers and institutions that can enable positive practice environments for women in pharmaceutical science and pharmacy education.

Learning objectives:
1. Explore the key factors that enable positive practice environments for women in pharmaceutical science and pharmacy education, and the entire pharmaceutical workforce
2. Learn about practical solutions for professionals, employers and policy makers in creating positive practice environments for women in pharmaceutical science and pharmacy education
3. Discuss with the toolkit authors and high-level speakers how to take action and standi up for positive practice environments

Moderator:
- Claire Thompson, Chair of FIPWiSE - UK
Facilitator:
- Nilhan Uzman, FIP Lead for Education Policy and Implementation - Netherlands

Panellists:
- Dominique Jordan, President FIP,Switzerland
- Catherine Duggan, CEO FIP, FIPWiSE Executive Sponsor,Netherlands
- Dalal Hammoudi, FIP WiSE steering committee member & FIP AMR commission member,Lebanon
- Ecehan Balta, FIPWiSE working group member,Turkey
- Nisa Masyitah, FIPWiSE Remote volunteer,Switzerland
- Alison Etukakpan, FIPWiSE working group member, Educational partnership coordinator FIP,Nigeria
- Aysu Selcuk, FIP Educational Partnerships Coordinator, FIPWiSE project coordinator,Turkey
- Belma Pehlivanović, FIPWiSE Remote volunteer,Bosnia and Herzegovina
- Esther Anyango, FIPWiSE Remote volunteer,Kenya
- Iris Mwanza, WGH Co-chair,USA
- Lina Bader, FIP Lead for EquityRx Program,SA

This digital event will discuss how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.

Learning objectives:
1. Discuss the impact of COVID-19 pandemic on the prevalence and evolution of the seasonal influenza around the world.
2. Explore relevance and importance of the influenza vaccination in the coming seasons.
3. Discuss ways to effectively develop confidence in influenza vaccines among the public.
4. Share learnings to address complacency towards the influenza vaccination including harnessing the role of community pharmacists.

Moderator:
-Luís Lourenço, Professional Secretary FIP, Portugal

Panellists:
-Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
-Samantha Marsh, Research fellow University of Auckland, National Institute for Health Innovation, New Zealand
- Dermot Twomey, President Irish Pharmacy Union, Ireland
- Danielle Paes, Chief Pharmacist Officer Canadian Pharmacists’ Association, Canada

New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?

Learning objectives:

• Understand the changing landscape of healthcare and pharmacy
• Identify how new actors use technology to transform pharmacy services
• Understand how digital transformation and tools support new business models and services, as well as is shaping a new patient/consumer behaviour
• Describe how FIPs PHC strategy and the DGs can be used to transform pharmacy practice
• Define a strategy for transform pharmacy linked to the "new normal"

Moderator:

• Lars-Åke Söderlund, President the FIP Community Pharmacy Section, Executive Advisor at Apoteket AB, Sweden
• Jacqueline Surugue, FIP Vice President, FIP Technology Forum Chair, Hospital Pharmacist at a 1300 beds hospital, France 

This webinar aims to highlight the different services provided by pharmacists in the prevention, screening and detection of diabetes. It will also demonstrate how pharmacists are providing such services in a time of pandemic.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:
1. Become familiar with services that pharmacists can provide in promoting the awareness of diabetes and adoption of healthy lifestyle
2. Recognise the role of pharmacists in the screening and detection of diabetes
3. Describe how the pandemic has influenced the delivery of diabetes services by pharmacists.

Moderator:
- Manjiri Gharat, FIP Vice-President, FIP, India

Panellists:
- Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal
- Margaret Wonah, Pharmacist, The Diabetes Care Network, Nigeria
- Mohamed Hassan Elnaem, Assistant Professor of Clinical Pharmacy, Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University, Malaysia

In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
- Dr. Ayman Noreddin - EMRO Education Leader and Dean at the College of Pharmacy, Galala University
- Dr. Lina Bader - Lead for Workforce Transformation & Development at FIP

The speakers at the event are:
- Dr. Ziad Nassour - Former President of the Lebanese Order of Pharmacists
- Dr. Madeeha Malik - Director/Professor - Hamdard Institute of Pharmaceutical Sciences
- Dr. Mohammed Al-Nuzili - Governing Board President of Yemen Community Pharmacy Syndicate
- Mr. Ahmed Abdulbary - Senior Regulatory Affairs Pharmacist at the National Health Regulatory Authority
- Prof. Rula Darwish – Professor at the University of Jordan. WDG9 Lead and member of executive committee of FIP academic section, and CPD chair of Jordan Pharmacist Association

This event will ask how healthcare can be rebuilt amidst a global pandemic and focus on the important role that selfcare will play. It will also look at the enablers that will accelerate self-care through community pharmacy and how this builds towards Universal Health Coverage.

Aim:
To identify mechanisms that will enable the acceleration of self-care to achieve UHC.

Learning objectives:
1. Discuss approaches to rebuilding healthcare during the COVID-19 pandemic
2. List factors that enable self-care through community pharmacy;
3. Describe trends in self-care;
4. Explain how to integrate self-care as a building block to Universal Health Coverage.

Target audience: Healthcare professionals – particularly the pharmacy team, who support people to self-care.

Moderator:
Sham Moodley, Community pharmacist

Panellists:
- Jurate Svarcaite, Director General Association of the European Self-Care Industry
- Ruben Viegas, FIP Practice Development Projects Coordinator
- Padmaja Kamath, Director – Regulatory and Scientific Affairs, Global Self-care Federation

The COVID-19 pandemic has exacerbated the existing mental health crisis. People have reportedly been affected by worry, anxiety and fear due to the pandemic. This has placed a huge strain on health systems and their ability to deliver mental health care. Pharmacists are the most accessible healthcare providers and consistently rank among the most trusted health professionals. Hence, they can play an important role in the provision of mental health services to the public, thereby helping improve health outcomes and ameliorate the impact on health systems. This webinar explores the different services offered by pharmacists to improve mental health in an era of COVID-19 and beyond.

At the end of this webinar, participants will:
1. Recognize the role of pharmacists in addressing the mental health crisis.
2. Understand the needs of people living with mental health illness
3. Describe the various services offered by pharmacists to members of the public in the area of mental health.
4. Be familiar with the tools and resources available for pharmacists to improve the mental health of their patients.

Moderator:
-Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia

Panellists:
- Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
- David Odhiambo, Pharmacist, Kenya
- Andrea Murphy, Associate Professor, Dalhousie University, Canada
- David Gardner, Professor, Dalhousie University, Canada
- Helena Roennfeldt, Consumer Mentor, Griffith University, Australia

This webinar will present the professional practice in the hospital setting using health digital technologies. Digital Innovation, how to develop digital skills in pharmacy personnel Telepharmacy and mHealth is the content of the first part. It is relevant to discuss “mHealth” because the access to mobile phones is almost universal and the costs of this technology will be able to be addressed by many countries. The objective of the second part will be: “Discuss current use of mHealth by patients and providers and the impact on hospital care in Midwestern United States” "Medication use technology" would complete the webinar.

Learning objectives:
1. Compare the “European” model of digital technologies for hospital pharmacy with the “American” one.
2. Explain the concept of medication error risk mitigation.
3. Get aware with Medication Use Technology employed throughout the medication use process

Moderator:
- Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, France 

Panellists:
- José Manuel Martínez Sesmero, Director of Pharmacy in Hospital Clínico San Carlos (Madrid), Spain
- Katherine A. Miller, Sr. Director – Acute Care Pharmacy and Clinical Nutrition,The University of Kansas Health System, USA
- Dr. Johlee S. Odinet, Johlee S. Odinet Medication Safety Supervisor  Ochsner Medical Center, USA

En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.

Acerca del programa - El programa digital 2021 de la FIP para transformar la vacunación a nivel mundial, regional y nacional comprende dos series, con un total de 12 eventos que se desarrollarán entre junio y noviembre.

In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region, join us for a true regional perspective.

This event will be moderated by:

• Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay
• Carlos Lacava – Vice President of Uruguayan Association of Chemistry and Pharmacy

The speakers at the event are:

• Dr. Kasey Thomspon - Chief Operating Officer and Senior Vice President of the American Society of Health-System Pharmacists (ASHP), USA
• Martha Rebour - Executive Director at Shot@Life, United Nations Foundation, USA
• Dr. Magaly Rodriguez de Bittner - Vice-President Pharmaceutical Forum of the Americas, USA

Facillitator:

• Rúben Viegas, Practice Development Projects Coordinator FIP, Spain

mRNA technology was used in developing the first ever COVID vaccine, developed by Pfizer / BioNtech. A number of vaccine or therapeutic products are in developing this technology. This webinare will address the following:

• What is mRNA? (structure and chemistry)
• How does it work in a cell (as either a therapeutic or vaccine)?
• How is it made and at what scale?
• How is it analyzed and characterized?
• By what means can it be delivered to the patient?
• What were the biggest challenges to get mRNA vaccines out to the public in 2020?
• What other notable clinical advances have been made for mRNA based medicines?
• What future directions do we see for mRNA as a therapeutic tool?

Moderator:

• Mathew Cherian, ExCo Member, Industrial Pharmacy Section Consultant, USA

Panellists:

• Michael McCaman PhD (U Cal at Davis), Managing Director, BDO USA
• Seth Alexandert PhD (Yale), Associate Director, Resilience, USA

This event will focus on the role that pharmacists can play in providing pharmaceutical care for people with hearing impairment or a disability linked to hearing loss. Pharmacists must provide clear messages and adapt their communication strategies to this particular population group to ensure optimal use of medicines and medical devices, and they need to have the knowledge and skills to do so. Also, people with hearing loss face different challenges and this problem becomes more relevant with age. Pharmacists can support patients in detecting early signs of hearing loss and taking the appropriate actions.

Learning objectives:

• Understand how hearing impairment or deafness impact a patient’s quality of life and their capacity to communicate with healthcare professionals.
• Learn about what pharmacists can do to support patients and carers with these conditions.
• Improve communication strategies to advise patients with hearing impairment on how to achieve an optimal use of medicines and medical devices.

Moderator:

• Tara Hehir, SAPS Secretary, Consultant Pharmacist, Australia

Panellists:

• Kasper Bergmann, Vice President World Federation of the Deaf, Denmark
• Kenneth Bitrus David, MSc Pharmacology and Drug Development Candidate Hull York Medical School, University of Hull, Nigeria/ United Kingdom
• Fiorella Donato Zúñiga, Pharmacist, Coordinator of "Programa Salud Inclusiva" (Inclusive Health Program) Acceso Visual , Costa Rica

Poor medication adherence has emerged as a major public health concern in the last decade, and pharmacists may play a vital role in medication adherence by implementing many of the solutions demonstrated at COVID-19.

FIP adapted the theme "Pharmacy: Always trusted for your health" for World Pharmacy Week; and expanding on that theme, FIP would like to welcome your attendance to this event. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1 to discuss the role of pharmacists in medication adherence and communication.
2 to share some regional and global thoughts on the common communication gaps and challenges that are experienced in all patient facing sectors
3 to highlight various regional and global strengths, accomplishments, and success stories in terms of medication adherence and communication in pharmacy.

FIP Technology Forum brings you the webinar about Virtual reality (VR). VR has been widely studied and applied in numerous medical applications. In pharmacy, VR can potentially be applied in wide range of activities, from drug design and discovery, though pharmacist education, to in-patient counseling and behavior modification. In this webinar we bring you the examples of VR technology applications in pharmacy. In our webinar, we will showcase and immersive virtual reality in a virtual environment with experience from Finland with our speaker Mia Siven from Helsinki University, where the VR was successfully applied in pharmacy education. We will then present a showcase of immersive virtual reality in a real environment, with speakers Agnes Bobay Madic and Paul Besnier with their example from France. VR technology has become increasingly affordable, flexible, and portable, enabling its use for therapeutic purposes in both inpatient and outpatient environments. But despite the compelling features of VR, a number of challenges exist, such as validation of clinical efficacy, cost/accessibility and usability issues, technical capabilities, acceptance, among others. You will have the opportunity to ask questions in the panel discussion part of the webinar.

Moderator:

• Jacqueline Surugue, FIP Vice President, Hospital Pharmacist, France

Panellists:

• Eeva Teräsalmi, Community Pharmacist, Owner Seven Brothers Pharmacy, Helsinki, Finland
• Mia Siven, FIP Technology Forum Chair Vice-Dean, University of Helsinki, Finland
• Agnès Bobay-Madic. Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
• Paul Besnier, Pharmacy Intern, Centre Hospitalier Universitaire de Caen Normandie, France

This event will describe Development Goal 12: Pharmacy Intelligence and explore latest developments in data and intelligence that supports health care. It will identify practical approaches to progress towards Development Goal 12.

Aim:
To discuss development goal 12 and how to ensure it supports health care.

Learning objectives:
1. Define pharmacy intelligence and explain priorities for its development (FIP Development Goal 12)
2. Discuss approaches to community pharmacy data collection
3. Explain the METNA project and its approach to data collection and needs assessment
4. List the functions of the GPO Atlas
5. Analyse and comment on possible indicators for DG12

Moderator
Professor Robert Sindelar, Chair – One FIP Data and Intelligence Commission, Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada

Panelists and Speakers
- Christopher John, Lead for Data and Intelligence, FIP, UK

- António Rodrigues, Executive Director - Portuguese Association of Pharmacies, Portugal

- Farah Aqqad, Regional Engagement and Project Coordinator, FIP, Jordan

- Dr Mira Zugic, President of the Pharmaceutical Chamber of Montenegro

- Dr Tanniru Narayana/Dr Rao Vadlamudi – Indian Pharmaceutical Association

- Mr. Nurul Falah Eddy Pariang, President – Indonesian Pharmacists Association.

- Sherly Meilianti, Data and Intelligence Specialist, FIP, UK/Indonesia

This event will focus on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists will also discuss working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

About the programme:
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

Moderator:
- Lina Bader - FIP Lead for Workforce Transformation & Development, Saudi Arabia 

Co-Moderator:
- Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay

Panellists:
- Daphne Holt, Chair of Coalition for Life-course Immunisation, France

- Meghna Joshi-Von Heyden, Strategic Development Advisor, Commonwealth Pharmacists Association (CPA), Switzerland

- Suresh Bhojraj, Patron at Indian Association of Colleges of Pharmacy and Pro Chancellor at JSS Academy of Higher Education and Research, Mysuru, India

- Marleen Haems, Director of Professional Management, KOVAG / VAN, Belgium

- Katarina Milosevic Konstadinovic, Community Pharmacist, Chairman of Assembly of Pharmaceutical Chamber of Montenegro, Montenegro

Counterfeit, substandard and falsified medications and medical products endanger public health and FIP believes that pharmacists and pharmaceutical scientists should contribute to patient safety by actively participating in the fight against counterfeit, substandard, and falsified medicines.
Adapting and expanding on the theme of World Pharmacy Week (Pharmacy: Always trusted for your health), we would like to invite you to attend this webinar and learn more about the role of pharmacists in the emerging threat of counterfeit, falsified, and substandard medicines. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1- to discuss the role of pharmacists in combating counterfeit, falsified, and substandard medicines.
2- to highlight various regional and global strengths, accomplishments, and success stories in the fight against counterfeit medications.
3- to identify emerging regional and global threats and challenges related to counterfeit medication.

Moderator:
- Lars-Åke Söderlund, President Swedish pharmaceutical society - Sweden 

Panellists:
- Catherine Duggan, CEO FIP, The Netherlands
- John Hertig, Vice-Chair and an Associate Professor of Pharmacy Practice, USA
- Manjiri Gharat, Vice-President, Indian Pharmaceutical Association, India
- Stephanie Kohl, Policy & Advocacy Officer, Belgium 
- Sally Galal, Associate Professor, Alexandria University, Egypt
- Dieudonne NZEYIMANA, Pharmacist and Sales Manager, Rwanda
- Renae Beardmore, Acting National President, Australia
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
- Pierre Souverain, Pfizer
- Caitriona Scott, Pfizer
- Gudrun Hubinger, Pfizer
- Zuzana Kusynová, Lead for Policy, Practice and Compliance, FIP, The Netherlands

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1. Describe the characteristics and epidemiology of the main VBDs in the European region;
2. Determine the roles that pharmacists can play in the prevention, detection, control and management of pharmacotherapy of VBDs; and
3. Identify the experiences developed by countries in Europe to support the actions of pharmacists in the fight against VBDs.

Moderator:
- Sari Westermarck, Community pharmacist, Finland

Panellists:
- Elkhan Gasimov, Technical Officer, Malaria, Neglected Tropical Diseases and other Vector-borne Diseases, World Health Organization Regional Office for Europe, Division of Country Health Programmes, Denmark

- Maria Dolores Bargues, Professor of Parasitology, University of Valencia and President of the Spanish Society of Tropical Medicine and International Health, University of Valencia, Spain

- Pınar Erkekoğlu, Head of Department of Toxicology, Hacettepe University Faculty of Pharmacy Department of Toxicology, Turkey

- Venelin Sapunarov, Chairman of the Board of the Regional Pharmaceutical College of Sofia, Bulgarian Pharmaceutical Union, Bulgaria

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The expected outcomes of the event are:

1. Describe the FIP Development Goals and explain the components of DG 13 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 13 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 13
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:
Catherine Duggan, CEO FIP, Netherlands

Panellists:
-Mahmoud Abdelrahman, President Egyptian Foundation of Clinical pharmacy EFCP, Egypt

- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP Australia

- Ramesh Walpola, Senior Lecturer School of Population Health, UNSW Sydney, Australia

-Virginia Olmos, Vice President AQFU, Uruguay

- Subhash Mandal, Vice President, Indian Pharmaceutical Association, India

- Ema Paulino, FIP Professional Secretar; Policy committee for statement on Women and RUM (Chair); General Manager, Ezfy, Portugal

- Eeva Teräsalmi, FIP Foundation Director Immediate Past Vice President of FIP, Finland

- Allie Jo Shipman, YPG Liaison to FIP Community Pharmacy Section; Director, National Alliance of State Pharmacy Associations, USA

- Luna Elbizri, Founder and Manager, Lunapharm Pharmacy, Lebanon

- Mary Ann Kliethermes, Director of Medication Safety and Quality, American Society of Health-System Pharmacists, USA

- Daragh Connolly, ExOfficio President, Irish Pharmacy Union, Ireland

- Certina Ho, Assistant Professor; Director, Educational Program Evaluation and Scholarship; Medication Safety Advisor, Department of Psychiatry; Leslie Dan Faculty of Pharmacy; University of Toronto; Institute for Safe Medication Practices Canada (ISMP Canada)

- Mariet Eksteen, Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-T.V. Narayana, President SEAR Pharm Forum, India

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
-Raj Vaidya, Community Pharmacist, Hindu Pharmacy, India

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE)

Panellists:
-Takuya Kumamoto, Professor, Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK)-United Kingdom
-Abdulaziz khaled Alkhaledi, Member of Executive Committee, Kuwait Pharmaceutical Association, Kuwait State